Thymus Therapy Scientific References:

1: Schulof RS. Thymic peptide hormones: basic properties and clinical applications in cancer. Crit Rev Oncol Hematol. 1985;3(4):309-76. Review. PubMed PMID: 3902261.

2: Low TL, Thurman GB, Chincarini C, McClure JE, Marshall GD, Hu SK, Goldstein AL. Current status of thymosin research: evidence for the existence of a family of thymic factors that control T-cell maturation. Ann N Y Acad Sci. 1979;332:33-48. Review. PubMed PMID: 394636.

3: Martin-Du-Pan RC. [Thymic hormones. Neuroendocrine interactions and clinical use in congenital and acquired immune deficiencies]. Ann Endocrinol (Paris). 1984;45(6):355-68. Review. French. PubMed PMID: 6399194.

4: Bach JF. Thymic hormones. J Immunopharmacol. 1979;1(3):277-310. Review. PubMed PMID: 233313.

5: Caso LV. Some endocrine aspects of the thymus gland. Jpn J Med Sci Biol. 1976 Dec;29(6):289-321. Review. PubMed PMID: 67231.

6: Wara DW. Thymic hormones and the immune system. Adv Pediatr. 1981;28:229-70. Review. PubMed PMID: 6280461.

7: Monier JC, Auger C, Fabien N. [Thymic hormones]. Arch Int Physiol Biochim.1988 Aug;96(3):A2-26. Review. French. PubMed PMID: 2463798.

8: Bodey B, Bodey B Jr, Siegel SE, Kaiser HE. Review of thymic hormones in cancer diagnosis and treatment. Int J Immunopharmacol. 2000 Apr;22(4):261-73. Review. PubMed PMID: 10689100.

9: Pahwa R, Ikehara S, Pahwa SG, Good RA. Thymic function in man. Thymus. 1979 Sep;1(1-2):27-58. PubMed PMID: 317931.

10: Haynes BF, Warren RW, Buckley RH, McClure JE, Goldstein AL, Henderson FW, Hensley LL, Eisenbarth GS. Demonstration of abnormalities in expression of thymic epithelial surface antigens in severe cellular immunodeficiency diseases. J Immunol. 1983 Mar;130(3):1182-8. PubMed PMID: 6600476.

11: Bach JF, Carnaud C. Thymic factors. Prog Allergy. 1976;21:342-408. Review. PubMed PMID: 12517.

12: Papiernik M. [The thymus micro-environment and T lymphocyte differentiation]. Reprod Nutr Dev. 1984;24(2):179-87. Review. French. PubMed PMID: 6369452.

13: Kruisbeek AM. Thymic factors and T cell maturation in vitro: a comparison of the effects of thymic epithelial cultures with thymic extracts and thymus dependent serum factors. Thymus. 1979 Nov;1(3):163-85. Review. PubMed PMID:162252.

14: Dardeene M, Bach JF. Thymic hormone in the treatment of cancer. Prog Clin Biol Res. 1989;288:363-82. Review. PubMed PMID: 2654955.

15: Bodey B. Thymic hormones in cancer diagnostics and treatment. Expert Opin Biol Ther. 2001 Jan;1(1):93-107. Review. PubMed PMID: 11727550.

16: Goldstein AL. Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer. Antibiot Chemother (1971). 1978;24:47-59. Review. PubMed PMID: 350140.

17: Spangelo BL. The thymic-endocrine connection. J Endocrinol. 1995 Oct;147(1):5-10. PubMed PMID: 7490536.

18: Dardenne M, Bach JF. [Functions of the thymus epithelium]. Rev Med Brux. 1985 Apr;6(4):239-42. French. PubMed PMID: 3890062.

19: Marshall GD Jr, Low TL, Thurman GB, Hu SK, Rossio JL, Trivers G, Goldstein AL. Overview of thymosin activity. Cancer Treat Rep. 1978 Nov;62(11):1731-7. PubMed PMID: 215305.

20: Ben-Efraim S, Keisari Y, Ophir R, Pecht M, Trainin N, Burstein Y. Immunopotentiating and immunotherapeutic effects of thymic hormones and factors with special emphasis on thymic humoral factor THF-gamma2. Crit Rev Immunol. 1999;19(4):261-84. Review. PubMed PMID: 10530429.

21: Covelli V, Munno I, Altamura M, Decandia P, Pellegrino NM, Marcuccio C, Caradonna L, Jirillo E. Role of thymic hormones in neuroimmunomodulation. Their use in patients with phobic disorders. Acta Neurol (Napoli). 1991 Oct;13(5):457-66. Review. PubMed PMID: 1776534.

22: Sztein MB, Goldstein AL. Thymic hormones–a clinical update. Springer Semin Immunopathol. 1986;9(1):1-18. Review. PubMed PMID: 3014672.

23: Schulof RS, Low TL, Thurman GB, Goldstein AL. Thymosins and other hormones of the thymus gland. Prog Clin Biol Res. 1981;58:191-215. Review. PubMed PMID: 7022481.

24: Renoux G. The thymic factor system. Biomed Pharmacother. 1983;37(9-10):433-40. Review. PubMed PMID: 6372883.

25: Haynes BF, Harden EA, Olanow CW, Eisenbarth GS, Wechsler AS, Hensley LL,Roses AD. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy. J Immunol.1983 Aug;131(2):773-7. PubMed PMID: 6408188.

26: Trainin N, Handzel ZT, Pecht M. Biological and clinical properties of THF.Thymus. 1985;7(3):137-50. PubMed PMID: 3875914.

27: Bach JF. Thymic hormones: biochemistry, and biological and clinicalactivities. Annu Rev Pharmacol Toxicol. 1977;17:281-91. Review. PubMed PMID: 17354.

28: Schulof RS, Goldstein AL. Thymosin and the endocrine thymus. Adv Intern Med. 1977;22:121-43. Review. PubMed PMID: 320839.

29: Attallah AM, Yeatman TJ, Johnson RP, Petricciani JC. Biological responsemodifiers and their promise in clinical medicine. Pharmacol Ther.1982;19(3):435-54. Review. PubMed PMID: 6201933.

30: Marshall GD Jr, Thurman GB, Low TL, Goldstein AL. Thymosin: basic properties and clinical application in the treatment of immunodeficiency diseases and cancer. Recent Results Cancer Res. 1980;75:100-5. PubMed PMID: 6262885.

31: Goldstein AL, Hooper JA, Schulof RS, Cohen GH, Thurman GB, McDaniel MC, WhiteA, Dardenne M. Thymosin and the immunopathology of aging. Fed Proc. 1974 Sep;33(9):2053-6. PubMed PMID: 4547564.

32: Giulling EV. [Role of the thymus in differentiation of cells of the lymphoid series]. Fiziol Zh. 1977 Nov-Dec;23(6):847-51. Review. Ukrainian. PubMed PMID: 338374.

33: Touraine JL. Induction of T lymphocyte differentiation by thymic factors. Mol Cell Biochem. 1981 Dec 4;41:119-22. PubMed PMID: 6977085.

34: Homo-Delarche F, Bach JF, Dardenne M. Thymic hormones and prostaglandins. I. Lack of stimulation of prostaglandin production by thymic hormones. Prostaglandins. 1989 Aug;38(2):183-96. PubMed PMID: 2788896.

35: Touraine JL, Touraine F. Thymic inducers of human T-lymphocyte differentiation in vitro and in vivo. Ann N Y Acad Sci. 1979;332:64-9. PubMed PMID: 161153.

36: Goldstein AL, Cohen GH, Thurman GB, Hooper JA, Rossio JL. Regulation of immune balance by thymosin: potential role in the development of suppressor T-cells. Adv Exp Med Biol. 1976;66:221-8. PubMed PMID: 773116.

37: Bach JF, Bach MA, Charreire J, Dardenne M, Pleau JM. The mode of action of thymic hormones. Ann N Y Acad Sci. 1979;332:23-32. Review. PubMed PMID: 231400.

38: Incefy GS, O’Reilly RJ, Kapoor N, Iwata T, Good RA. In vitro differentiation of human marrow T cell precursors by thymic factors in severe combined immunodeficiency. Transplantation. 1981 Oct;32(4):299-305. PubMed PMID: 6977211.

39: Fabien N, Auger C, Monier JC. Immunolocalization of thymosin alpha 1,thymopoietin and thymulin in mouse thymic epithelial cells at different stages of culture: a light and electron microscopic study. Immunology. 1988 Apr;63(4):721-7. PubMed PMID: 3284819; PubMed Central PMCID: PMC1454785.

40: Hong R. Reconstitution of T-cell deficiency by thymic hormone or thymus transplantation therapy. Clin Immunol Immunopathol. 1986 Jul;40(1):136-41. Review. PubMed PMID: 3521966.

41: Lunin SM, Novoselova EG. Thymus hormones as prospective anti-inflammatory agents. Expert Opin Ther Targets. 2010 Aug;14(8):775-86. doi: 10.1517/14728222.2010.499127. Review. PubMed PMID: 20536297.

42: Rubinstein A, Novick BE, Sicklick MJ, Bernstein LJ, Incefy GS, Naylor PH,Goldstein AL. Circulating thymulin and thymosin-alpha 1 activity in pediatric acquired immune deficiency syndrome: in vivo and in vitro studies. J Pediatr.1986 Sep;109(3):422-7. PubMed PMID: 3018210.

43: Khan A. Thymic hormones and immunopeptides. Ann Allergy. 1978 Aug;41(2):78-83. PubMed PMID: 308333.

44: Goya RG, Brown OA, Bolognani F. The thymus-pituitary axis and its changes during aging. Neuroimmunomodulation. 1999 Jan-Apr;6(1-2):137-42. Review. PubMed PMID: 9876244.

45: Bodey B, Bodey B Jr, Siegel SE, Kaiser HE. The role of the reticulo-epithelial (RE) cell network in the immuno-neuroendocrine regulation of intrathymic lymphopoiesis. Anticancer Res. 2000 May-Jun;20(3A):1871-88. PubMed PMID: 10928121.

46: Tovo PA, Davi G, Fraceschini P, Delpiano A. Thymic hormone dependent immunodeficiency in an infant with partial trisomy of chromosome 22. Thymus. 1986;8(5):313-8. PubMed PMID: 3798528.

47: Grinevich IuA, Fil’chakov FV, Gomberg EG. [Effect of thymostimulin on thymic serum activity and the expression of E-receptor by guinea pig lymphocytes in late thymectomy]. Fiziol Zh. 1988 Mar-Apr;34(2):79-84. Russian. PubMed PMID: 3391311.

48: Savino W, de Mello-Coelho V, Dardenne M. Control of the thymic microenvironment by growth hormone/insulin-like growth factor-I-mediated circuits. Neuroimmunomodulation. 1995 Nov-Dec;2(6):313-8. Review. PubMed PMID:8840333.

49: Ho AD, Ma DD, Price G, Hunstein W, Hoffbrand AV. Biochemical and immunological differentiation of human thymocytes induced by thymic hormones. Immunology. 1983 Nov;50(3):471-6. PubMed PMID: 6605305; PubMed Central PMCID:PMC1454273.

50: Incefy GS, Boumsell L, Kagan W, Goldstein G, Sousa MD, Smithwick E, O’Reilly R, Good RA. Enhancement of T lymphocyte differentiation in vitro by thymic extracts and purified polypeptides in severe combined immunodeficiency diseases. Trans Assoc Am Physicians. 1975;88:135-45. PubMed PMID: 772925.

51: Bach JF. One or several thymic hormones? Recent Results Cancer Res.1980;75:106-9. PubMed PMID: 6972070.

52: Bendiug GD, Kamenets LIa, Nikol’skii IS, Grinevich IuA. [Characteristics of the inhibition of thymus endocrine function and synthesis of substances with thymosin-like activity caused by thymostimulin and splenin during DMBA-inducedmammary gland carcinogenesis in rats]. Eksp Onkol. 1987;9(3):54-7. Russian. PubMed PMID: 3111825.

53: Goldstein AL, Low TL, McAdoo M, McClure J, Thurman GB, Rossio J, Lai CY,Chang D, Wang SS, Harvey C, Ramel AH, Meienhofer J. Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide. Proc Natl Acad Sci U S A. 1977 Feb;74(2):725-9. PubMed PMID: 265536; PubMed Central PMCID: PMC392366.

54: Low TL, Goldstein AL. Thymosins: structure, function and therapeutic applications. Thymus. 1984;6(1-2):27-42. Review. PubMed PMID: 6087503.

55: Markovic L. [Interaction involving the thymus and the hypothalamus-pituitary axis, immunomodulation by hormones]. Srp Arh Celok Lek. 2004 May-Jun;132(5-6):187-93. Review. Serbian. PubMed PMID: 15493593.

56: Consolini R, Cini P, Cei B, Bottone E. Thymic dysfunction in histiocytosis-X.Am J Pediatr Hematol Oncol. 1987 Summer;9(2):146-8. PubMed PMID: 2954482.

57: Murthy KK, Ragland WL. Immunomodulation by thymic hormones: studies with an avian thymic hormone. Prog Clin Biol Res. 1984;161:481-91. PubMed PMID: 6333034.

58: Low TL, Goldstein AL. Thymic hormones: an overview. Methods Enzymol.1985;116:213-9. PubMed PMID: 4088084.

59: Nikolsky IS, Seleznyova TN, Zamotayeva GA, Martynenko SV, Grinevich YuA.Production of substances with thymosin-like activity by B- and T-lymphocytes. J Hyg Epidemiol Microbiol Immunol. 1990;34(3):309-14. PubMed PMID: 2273248.

60: D’Amelio R. [Immunotherapy today. II. Immunostimulating therapy]. Riv Med Aeronaut Spaz. 1978 Jan-Mar;41(1):75-114. Italian. PubMed PMID: 93770.

61: Goya RG, Bolognani F. Homeostasis, thymic hormones and aging. Gerontology.1999 May-Jun;45(3):174-8. Review. PubMed PMID: 10202264.

62: Low TL, Thurman GB, McAdoo M, McClure J, Rossio JL, Naylor PH, Goldstein AL. The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus. J Biol Chem. 1979 Feb 10;254(3):981-6. PubMed PMID: 216684.

63: Di Sabato G. Biochemical aspects of the function of the thymus gland. Horiz Biochem Biophys. 1977;3:297-325. Review. PubMed PMID: 69602.

64: Brugo MA, Valcurone G, Tassi GC. [Thymus hormone reviewed]. Recenti Prog Med.1978 Sep;65(3):244-76. Review. Italian. PubMed PMID: 360328.

65: Ramagopal S, Reem GH. Activities of purine nucleotide metabolizing enzymes in human thymocytes and peripheral blood T lymphocytes: in vitro effect of thymic hormones. Thymus. 1982 May;4(3):163-72. PubMed PMID: 6287680.

66: Trainin N. Prospects of AIDS therapy by thymic humoral factor, a thymic hormone. Nat Immun Cell Growth Regul. 1990;9(3):155-9. Review. PubMed PMID: 2196458.

67: Comsa J. The thymic hormones. Hormones. 1971;2(4):226-55. Review. PubMed PMID: 5006663.

68: Thurman GB, Goldstein AL. The role of thymosin in lymphocyte maturation. Boll Ist Sieroter Milan. 1975 Jul 31;54(3):203-10. PubMed PMID: 1082758.

69: Shoham J, Eshel I. Thymic hormonal effect on human peripheral blood lymphocytes in vitro. III. Conditions for mixed lymphocyte-tumor culture assay. J Immunol Methods. 1980;37(3-4):261-72. PubMed PMID: 7192720.

70: Kaufman DB. Maturational effects of thymic hormones on human helper and suppressor T cells: effects of FTS (‘Facteur Thymique Sérique’) and thymosin. Clin Exp Immunol. 1980 Mar;39(3):722-7. PubMed PMID: 6445799; PubMed Central PMCID: PMC1538127.

71: Goldstein AL, Badamchian M. Thymosins: chemistry and biological properties in health and disease. Expert Opin Biol Ther. 2004 Apr;4(4):559-73. Review. PubMed PMID: 15102605.

72: Monier JC, Auger C, Corvee N, Stahli C, Fabien N. Immunoreactivity of aqueous extracts of rat and mouse tissue with anti-thymosin alpha 1, anti-bovine thymopoietin and anti-thymulin antibodies. Studies using immunoblotting. Thymus. 1988;11(3):173-83. PubMed PMID: 3363629.

73: Simon HU, Roth H, Forner K, Haroske D. [Immunological status of patients with recurrent herpes simplex infections. In vitro effect of thymopoietin and splenin-derived and partially modified peptides on peripheral blood lymphocytes in comparison to a thymus extract]. Allerg Immunol (Leipz). 1990;36(2):111-8. German. PubMed PMID: 1975471.

74: Berthiaume F, Aparicio CL, Eungdamrong J, Yarmush ML. Age- and disease-related decline in immune function: an opportunity for “thymus-boosting” therapies. Tissue Eng. 1999 Dec;5(6):499-514. Review. PubMed PMID: 10611542.

75: Wara DW, Goldstein AL, Doyle NE, Ammann AJ. Thymosin activity in patients with cellular immunodeficiency. N Engl J Med. 1975 Jan 9;292(2):70-4. PubMed PMID: 1078552.

76: Incefy GS, Mertelsmann R, Yata K, Dardenne M, Bach JF, Good RA. Induction of differentiation in human marrow T cell precursors by the synthetic serum thymic factor, FTS. Clin Exp Immunol. 1980 May;40(2):396-406. PubMed PMID: 6969145;PubMed Central PMCID: PMC1536979.

77: Ciardelli TL, Incefy GS, Birr C. Activity of synthetic thymosin alpha 1 C-terminal peptides in the azathioprine E-rosette inhibition assay. Biochemistry. 1982 Aug 31;21(18):4233-7. PubMed PMID: 6982069.

78: Fabris N, Mocchegiani E, Mariotti S, Pacini F, Pinchera A. Thyroid function modulates thymic endocrine activity. J Clin Endocrinol Metab. 1986 Mar;62(3):474-8. PubMed PMID: 3944232.

79: Which thymic hormone? Lancet. 1983 Jun 11;1(8337):1309-11. PubMed PMID:6134098.

80: Kendall MD. Have we underestimated the importance of the thymus in man?Experientia. 1984 Nov 15;40(11):1181-5. Review. PubMed PMID: 6389172.

81: Dardenne M. Role of thymic peptides as transmitters between theneuroendocrine and immune systems. Ann Med. 1999 Oct;31 Suppl 2:34-9. Review. PubMed PMID: 10574153.

82: Dalakas MC, Rose JW, Paul J, Engel WK, McClure JE, Goldstein AL. Increased circulation of T lymphocytes bearing surface thymosin alpha 1 in patients with myasthenia gravis: effect of thymectomy. Neurology. 1983 Feb;33(2):144-9. PubMed PMID: 6337347.

83: D’Souza BG, Pai SR. Response of lymphoid cells to thymic hormonal factors isolated from mouse thymus. Cancer Biochem Biophys. 1990 Jul;11(3):227-37. PubMed PMID: 2268852.

84: Ho AD, Stehle B, Birr C, Heinzel W, Nebe TC. Differentiation changes in cord blood T lymphocytes induced by synthetic C-terminal peptides of thymosin alpha 1. Thymus. 1987;9(2):77-84. PubMed PMID: 3035761.

85: Levinsky RJ, Davies EG, Goldstein G. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies. Birth Defects Orig Artic Ser. 1983;19(3):273-6. PubMed PMID: 6360239.

86: Heavner GA. Thymopentin structure and relation to thymic factors. Surv Immunol Res. 1985;4 Suppl 1:11-6. PubMed PMID: 3898282.

87: Goldstein AL, Low TL, Thurman GB, Zatz MM, Hall N, Chen J, Hu SK, Naylor PB, McClure JE. Current status of thymosin and other hormones of the thymus gland. Recent Prog Horm Res. 1981;37:369-415. Review. PubMed PMID: 7025134.

88: Bodey B, Bodey B Jr, Siegel SE, Kaiser HE. Involution of the mammalian thymus, one of the leading regulators of aging. In Vivo. 1997 Sep-Oct;11(5):421-40. PubMed PMID: 9427047.

89: Haynes BF, Warren RW, Buckley RH, McClure JE, Goldstein AL, Henderson FW,Hensley LL, Eisenbarth GS. Demonstration of abnormalities in expression of thymic epithelial surface antigens in severe cellular immunodeficiency diseases. Birth Defects Orig Artic Ser. 1983;19(3):255-8. PubMed PMID: 6606445.

90: Goldstein AL. The Gordon Wilson lecture. The history of the development of thymosin: chemistry, biology and clinical applications. Trans Am Clin Climatol Assoc. 1977;88:79-94. PubMed PMID: 331647; PubMed Central PMCID: PMC2441421.

91: Fiorilli M, Sirianni MC, Pandolfi F, Quinti I, Tosti U, Aiuti F, Goldstein G.Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency. Clin Exp Immunol. 1981 Aug;45(2):344-51. PubMed PMID: 7032772; PubMed Central PMCID: PMC1537373.

92: Mizuno Y, Matsumaru A, Munakata Y, Funatsu K, Muraoka M, Shimabukuro K,Hashimoto S, Nakamura T, Tsuchiya M. [Thymic humoral factor produced by a thymic epithelial culture]. Nihon Kyobu Shikkan Gakkai Zasshi. 1985 Jan;23(1):17-23.Japanese. PubMed PMID: 4040185.

93: Wara DW, Ammann AJ. Thymosin treatment of children with primary immunodeficiency disease. Transplant Proc. 1978 Mar;10(1):203-9. PubMed PMID: 305674.

94: Sobolev SM, Stepanova TN. [Thymic hormonal effects on the antigen-dependent differentiation of accessory T-lymphocytes in the humoral immune response]. Ontogenez. 1986 Jan-Feb;17(1):62-9. Russian. PubMed PMID: 3960463.

95: Kinoshita Y, Hato F. Cellular and molecular effects of thymic epithelial cells on thymocytes during differentiation and maturation. Int Rev Cytol. 1994;156:159-98. Review. PubMed PMID: 7860216.

96: Imhof BA, Deugnier MA, Itoh T, Thiery JP. T lymphocyte precursors migrate towards chemotactic peptides secreted by embryonic or juvenile thymus. Adv Exp Med Biol. 1988;237:565-70. PubMed PMID: 3267062.

97: Goldstein AL, Thurman GB, Rossio JL, Costanzi JJ. Immunologic reconstitution of patients with primary immunodeficiency diseases and cancer after treatment with thymosin. Transplant Proc. 1977 Mar;9(1):1141-4. PubMed PMID: 325742.

98: Handzel ZT, Elitsur Y, Algrimawi S, Moses S, Keynan A, Amitai I, Pecht M,Burstein Y, Buchner V, Trainin N. Treatment of congenital immune deficiencies with a thymic hormone–thymic humoral factor. Isr J Med Sci. 1986 May;22(5):387-92. PubMed PMID: 3528049.

99: Kinoshita Y, Hato F. Cellular and molecular interactions of thymus with endocrine organs and nervous system. Cell Mol Biol (Noisy-le-grand). 2001 Feb;47(1):103-17. Review. PubMed PMID: 11292245.

100: Chen SS, Tung JS, Gillis S, Good RA, Hadden JW. Changes in surface antigens of immature thymocytes under the influence of T-cell growth factor and thymic factors. Proc Natl Acad Sci U S A. 1983 Oct;80(19):5980-4. PubMed PMID: 6604276; PubMed Central PMCID: PMC390201.

 

Chelation Therapy Scientific References:

1: Houston MC. The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. Altern Ther Health Med. 2007 Mar-Apr;13(2):S128-33. Review. PubMed PMID: 17405690.

2: Houston MC. Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. J Clin Hypertens (Greenwich). 2011 Aug;13(8):621-7. doi: 10.1111/j.1751-7176.2011.00489.x. Epub 2011 Jul 11. Review. PubMed PMID: 21806773.

3: Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12(10):1161-208. Review. PubMed PMID: 15892631.

4: Järup L. Hazards of heavy metal contamination. Br Med Bull. 2003;68:167-82.Review. PubMed PMID: 14757716.

5: Wolf MB, Baynes JW. Cadmium and mercury cause an oxidative stress-induced endothelial dysfunction. Biometals. 2007 Feb;20(1):73-81. Epub 2006 Jun 4. PubMed PMID: 16752219.

6: Ercal N, Gurer-Orhan H, Aykin-Burns N. Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem. 2001 Dec;1(6):529-39. Review. PubMed PMID: 11895129.

7: Monnet-Tschudi F, Zurich MG, Boschat C, Corbaz A, Honegger P. Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases. Rev Environ Health. 2006 Apr-Jun;21(2):105-17. Review. PubMed PMID: 16898674.

8: Strubelt O, Kremer J, Tilse A, Keogh J, Pentz R, Younes M. Comparative studies on the toxicity of mercury, cadmium, and copper toward the isolated perfused rat liver. J Toxicol Environ Health. 1996 Feb 23;47(3):267-83. PubMed PMID: 8604150.

9: Chowdhury BA, Chandra RK. Biological and health implications of toxic heavy metal and essential trace element interactions. Prog Food Nutr Sci. 987; 11(1):55-113. Review. PubMed PMID: 3303135.

10: Canesi L, Ciacci C, Piccoli G, Stocchi V, Viarengo A, Gallo G. In vitro and in vivo effects of heavy metals on mussel digestive gland hexokinase activity: the role of glutathione. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol.1998 Aug;120(2):261-8. PubMed PMID: 9827040.

11: Collin-Hansen C, Andersen RA, Steinnes E. Damage to DNA and lipids in Boletus edulis exposed to heavy metals. Mycol Res. 2005 Dec;109(Pt 12):1386-96. PubMed PMID: 16353638.

12: Sharma SK, Goloubinoff P, Christen P. Heavy metal ions are potent inhibitors of protein folding. Biochem Biophys Res Commun. 2008 Jul 25;372(2):341-5. doi: 10.1016/j.bbrc.2008.05.052. Epub 2008 May 21. PubMed PMID: 18501191.

13: Kuliczkowski W, Jolda-Mydlowska B, Kobusiak-Prokopowicz M, Antonowicz-Juchniewicz J, Kosmala W. [Effect of heavy metal ions on function of vascular endothelium in patients with ischemic heart disease]. Pol Arch Med Wewn. 2004 Jun;111(6):679-85. Polish. PubMed PMID: 15508790.

14: Sanchez-Galan S, Linde AR, Ayllon F, Garcia-Vazquez E. Induction of micronuclei in eel (Anguilla anguilla L.) by heavy metals. Ecotoxicol Environ Saf. 2001 Jun;49(2):139-43. PubMed PMID: 11386727.

15: Li W, Mao R, Liu X. [Effects of stress duration and non-toxic ions on heavy metals toxicity to Arabidopsis seed germination and seedling growth]. Ying Yong Sheng Tai Xue Bao. 2005 Oct;16(10):1943-7. Chinese. PubMed PMID: 16422519.

16: Pollock B, Machin KL. Effects of cadmium, mercury, and selenium on reproductive indices in male lesser scaup (Aythya affinis) in the western Boreal forest. Arch Environ Contam Toxicol. 2008 May;54(4):730-9. Epub 2007 Oct 30. PubMed PMID: 17968482.

17: Hultberg B, Andersson A, Isaksson A. Alterations of thiol metabolism in human cell lines induced by low amounts of copper, mercury or cadmium ions. Toxicology. 1998 Apr 3;126(3):203-12. PubMed PMID: 9674968.

18: Kaji T. [Cell biology of heavy metal toxicity in vascular tissue]. Yakugaku Zasshi. 2004 Mar;124(3):113-20. Review. Japanese. PubMed PMID: 15049128.

19: Patrick L. Toxic metals and antioxidants: Part II. The role of antioxidants in arsenic and cadmium toxicity. Altern Med Rev. 2003 May;8(2):106-28. Review. PubMed PMID: 12777158.

20: Evans DH, Weingarten K. The effect of cadmium and other metals on vascular smooth muscle of the dogfish shark, Squalus acanthias. Toxicology. 1990 Apr 30;61(3):275-81. PubMed PMID: 2330599.

21: Lim SR, Schoenung JM. Human health and ecological toxicity potentials due to heavy metal content in waste electronic devices with flat panel displays. J Hazard Mater. 2010 May 15;177(1-3):251-9. doi: 10.1016/j.jhazmat.2009.12.025. Epub 2009 Dec 11. PubMed PMID: 20056318.

22: Flora SJ, Mittal M, Mehta A. Heavy metal induced oxidative stress & its possible reversal by chelation therapy. Indian J Med Res. 2008 Oct;128(4):501-23. Review. PubMed PMID: 19106443.

23: Johri N, Jacquillet G, Unwin R. Heavy metal poisoning: the effects of cadmium on the kidney. Biometals. 2010 Oct;23(5):783-92. doi: 10.1007/s10534-010-9328-y. Epub 2010 Mar 31. Review. PubMed PMID: 20354761.

24: Moreira JC. Threats by heavy metals: human and environmental contamination in Brazil. Sci Total Environ. 1996 Sep;188 Suppl 1:S61-71. Review. PubMed PMID: 8888629.

25: Rana SV, Kumar A, Bhardwaj NG, Kumar A. Lipids in the liver and kidney of rats, fed various heavy metals. Acta Anat (Basel). 1980;108(3):402-12. PubMed PMID: 7415805.

26: Borges VC, Santos FW, Rocha JB, Nogueira CW. Heavy metals modulate glutamatergic system in human platelets. Neurochem Res. 2007 Jun;32(6):953-8. Epub 2007 Apr 4. PubMed PMID: 17406985.

27: Ortega-Villasante C, Rellán-Alvarez R, Del Campo FF, Carpena-Ruiz RO, Hernández LE. Cellular damage induced by cadmium and mercury in Medicago sativa. J Exp Bot. 2005 Aug;56(418):2239-51. Epub 2005 Jul 4. PubMed PMID: 15996984.

28: Wayland M, Gilchrist HG, Marchant T, Keating J, Smits JE. Immune function, stress response, and body condition in arctic-breeding common eiders in relation to cadmium, mercury, and selenium concentrations. Environ Res. 2002 Sep;90(1):47-60. PubMed PMID: 12359190.

29: Kappus H, Reinhold C. Heavy metal-induced cytotoxicity to cultured human epidermal keratinocytes and effects of antioxidants. Toxicol Lett. 1994 Apr;71(2):105-9. PubMed PMID: 8171440.

30: Lukacínová A, Rácz O, Lovásová E, Ništiar F. Effect of lifetime low dose exposure to heavy metals on selected serum proteins of Wistar rats during three subsequent generations. Ecotoxicol Environ Saf. 2011 Sep;74(6):1747-55. doi: 10.1016/j.ecoenv.2011.04.017. Epub 2011 May 6. PubMed PMID: 21549428.

31: Ognjanovic BI, Markovic SD, Pavlovic SZ, Zikic RV, Stajn AS, Saicic ZS. Effect of chronic cadmium exposure on antioxidant defense system in some tissues of rats: protective effect of selenium. Physiol Res. 2008;57(3):403-11. Epub 2007 Apr 25. PubMed PMID: 17465690.

32: Suzuki N, Yamamoto M, Watanabe K, Kambegawa A, Hattori A. Both mercury and cadmium directly influence calcium homeostasis resulting from the suppression of scale bone cells: the scale is a good model for the evaluation of heavy metals in bone metabolism. J Bone Miner Metab. 2004;22(5):439-46. PubMed PMID: 15316864.

33: Benkoel L, Dodero F, Roussel E, Baudin JC, Lambert R, Chamlian A, Augier H. Hepatotoxic effect of metallic pollutants on enzyme histochemical activities of yellow-legged gull Larus cachinnans michahellis liver. Cell Mol Biol (Noisy-le-grand). 2000 Nov;46(7):1183-9. PubMed PMID: 11075948.

34: Yamamoto C. [Toxicity of cadmium and lead on vascular cells that regulate fibrinolysis]. Yakugaku Zasshi. 2000 May;120(5):463-73. Review. Japanese. PubMed PMID: 10825810.

35: Costa A, Branca V, Minoia C, Pigatto PD, Guzzi G. Heavy metals exposure and electromagnetic hypersensitivity. Sci Total Environ. 2010 Sep 15;408(20):4919-20; author reply 4921. doi: 10.1016/j.scitotenv.2010.06.045. PubMed PMID: 20643474.

36: Moon SS. Association of lead, mercury and cadmium with diabetes in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. Diabet Med. 2013 Apr;30(4):e143-8. doi: 10.1111/dme.12103. PubMed PMID: 23278294.

37: Wilks MF, Kwizera EN, Bach PH. Assessment of heavy metal nephrotoxicity in vitro using isolated rat glomeruli and proximal tubular fragments. Ren Physiol Biochem. 1990 Sep-Oct;13(5):275-84. PubMed PMID: 1697089.

38: Rehwoldt R, Menapace LW, Nerrie B, Alessandrello D. The effect of increased temperature upon the acute toxicity of some heavy metal ions. Bull Environ Contam Toxicol. 1972 Aug;8(2):91-6. PubMed PMID: 5077496.

39: Liu J, Qu W, Kadiiska MB. Role of oxidative stress in cadmium toxicity and carcinogenesis. Toxicol Appl Pharmacol. 2009 Aug 1;238(3):209-14. doi: 10.1016/j.taap.2009.01.029. Epub 2009 Feb 21. Review. PubMed PMID: 19236887.

40: Boujbiha MA, Hamden K, Guermazi F, Bouslama A, Omezzine A, Kammoun A, El Feki A. Testicular toxicity in mercuric chloride treated rats: association with oxidative stress. Reprod Toxicol. 2009 Jul;28(1):81-9. doi: 10.1016/j.reprotox.2009.03.011. Epub 2009 Apr 5. PubMed PMID: 19427169.

41: Satarug S, Nishijo M, Lasker JM, Edwards RJ, Moore MR. Kidney dysfunction and hypertension: role for cadmium, p450 and heme oxygenases? Tohoku J Exp Med. 2006 Mar;208(3):179-202. Review. PubMed PMID: 16498227.

42: Markovich D, James KM. Heavy metals mercury, cadmium, and chromium inhibit the activity of the mammalian liver and kidney sulfate transporter sat-1. Toxicol Appl Pharmacol. 1999 Jan 15;154(2):181-7. PubMed PMID: 9925802.

43: Houston MC. The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. Altern Ther Health Med. 2007 Mar-Apr;13(2):S128-33. Review. PubMed PMID: 17405690.

44: Houston MC. Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. J Clin Hypertens (Greenwich). 2011 Aug;13(8):621-7. doi: 10.1111/j.1751-7176.2011.00489.x. Epub 2011 Jul 11. Review. PubMed PMID: 21806773.

45: Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12(10):1161-208. Review. PubMed PMID: 15892631.

46: Järup L. Hazards of heavy metal contamination. Br Med Bull. 2003;68:167-82. Review. PubMed PMID: 14757716.

47: Wolf MB, Baynes JW. Cadmium and mercury cause an oxidative stress-induced endothelial dysfunction. Biometals. 2007 Feb;20(1):73-81. Epub 2006 Jun 4. PubMed PMID: 16752219.

48: Ercal N, Gurer-Orhan H, Aykin-Burns N. Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem. 2001 Dec;1(6):529-39. Review. PubMed PMID: 11895129.

49: Monnet-Tschudi F, Zurich MG, Boschat C, Corbaz A, Honegger P. Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases. Rev Environ Health. 2006 Apr-Jun;21(2):105-17. Review. PubMed PMID: 16898674.

50: Strubelt O, Kremer J, Tilse A, Keogh J, Pentz R, Younes M. Comparative studies on the toxicity of mercury, cadmium, and copper toward the isolated perfused rat liver. J Toxicol Environ Health. 1996 Feb 23;47(3):267-83. PubMed PMID: 8604150.

51: Chowdhury BA, Chandra RK. Biological and health implications of toxic heavy metal and essential trace element interactions. Prog Food Nutr Sci. 1987;11(1):55-113. Review. PubMed PMID: 3303135.

52: Canesi L, Ciacci C, Piccoli G, Stocchi V, Viarengo A, Gallo G. In vitro and in vivo effects of heavy metals on mussel digestive gland hexokinase activity: the role of glutathione. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998 Aug;120(2):261-8. PubMed PMID: 9827040.

53: Collin-Hansen C, Andersen RA, Steinnes E. Damage to DNA and lipids in Boletus edulis exposed to heavy metals. Mycol Res. 2005 Dec;109(Pt 12):1386-96. PubMed PMID: 16353638.

54: Sharma SK, Goloubinoff P, Christen P. Heavy metal ions are potent inhibitors of protein folding. Biochem Biophys Res Commun. 2008 Jul 25;372(2):341-5. doi: 10.1016/j.bbrc.2008.05.052. Epub 2008 May 21. PubMed PMID: 18501191.

55: Kuliczkowski W, Jolda-Mydlowska B, Kobusiak-Prokopowicz M, Antonowicz-Juchniewicz J, Kosmala W. [Effect of heavy metal ions on function of vascular endothelium in patients with ischemic heart disease]. Pol Arch Med Wewn. 2004 Jun;111(6):679-85. Polish. PubMed PMID: 15508790.

56: Sanchez-Galan S, Linde AR, Ayllon F, Garcia-Vazquez E. Induction of micronuclei in eel (Anguilla anguilla L.) by heavy metals. Ecotoxicol Environ Saf. 2001 Jun;49(2):139-43. PubMed PMID: 11386727.

57: Li W, Mao R, Liu X. [Effects of stress duration and non-toxic ions on heavy metals toxicity to Arabidopsis seed germination and seedling growth]. Ying Yong Sheng Tai Xue Bao. 2005 Oct;16(10):1943-7. Chinese. PubMed PMID: 16422519.

58: Pollock B, Machin KL. Effects of cadmium, mercury, and selenium on reproductive indices in male lesser scaup (Aythya affinis) in the western Boreal forest. Arch Environ Contam Toxicol. 2008 May;54(4):730-9. Epub 2007 Oct 30. PubMed PMID: 17968482.

59: Hultberg B, Andersson A, Isaksson A. Alterations of thiol metabolism in human cell lines induced by low amounts of copper, mercury or cadmium ions. Toxicology. 1998 Apr 3;126(3):203-12. PubMed PMID: 9674968.

60: Kaji T. [Cell biology of heavy metal toxicity in vascular tissue]. Yakugaku Zasshi. 2004 Mar;124(3):113-20. Review. Japanese. PubMed PMID: 15049128.

61: Patrick L. Toxic metals and antioxidants: Part II. The role of antioxidants in arsenic and cadmium toxicity. Altern Med Rev. 2003 May;8(2):106-28. Review. PubMed PMID: 12777158.

62: Evans DH, Weingarten K. The effect of cadmium and other metals on vascular smooth muscle of the dogfish shark, Squalus acanthias. Toxicology. 1990 Apr 30;61(3):275-81. PubMed PMID: 2330599.

63: Lim SR, Schoenung JM. Human health and ecological toxicity potentials due to heavy metal content in waste electronic devices with flat panel displays. J Hazard Mater. 2010 May 15;177(1-3):251-9. doi: 10.1016/j.jhazmat.2009.12.025. Epub 2009 Dec 11. PubMed PMID: 20056318.

64: Flora SJ, Mittal M, Mehta A. Heavy metal induced oxidative stress & its possible reversal by chelation therapy. Indian J Med Res. 2008 Oct;128(4):501-23. Review. PubMed PMID: 19106443.

65: Johri N, Jacquillet G, Unwin R. Heavy metal poisoning: the effects of cadmium on the kidney. Biometals. 2010 Oct;23(5):783-92. doi: 10.1007/s10534-010-9328-y. Epub 2010 Mar 31. Review. PubMed PMID: 20354761.

66: Moreira JC. Threats by heavy metals: human and environmental contamination in Brazil. Sci Total Environ. 1996 Sep;188 Suppl 1:S61-71. Review. PubMed PMID: 8888629.

67: Rana SV, Kumar A, Bhardwaj NG, Kumar A. Lipids in the liver and kidney of rats, fed various heavy metals. Acta Anat (Basel). 1980;108(3):402-12. PubMed PMID: 7415805.

68: Borges VC, Santos FW, Rocha JB, Nogueira CW. Heavy metals modulate glutamatergic system in human platelets. Neurochem Res. 2007 Jun;32(6):953-8. Epub 2007 Apr 4. PubMed PMID: 17406985.

69: Ortega-Villasante C, Rellán-Alvarez R, Del Campo FF, Carpena-Ruiz RO, Hernández LE. Cellular damage induced by cadmium and mercury in Medicago sativa. J Exp Bot. 2005 Aug;56(418):2239-51. Epub 2005 Jul 4. PubMed PMID: 15996984.

70: Wayland M, Gilchrist HG, Marchant T, Keating J, Smits JE. Immune function, stress response, and body condition in arctic-breeding common eiders in relation to cadmium, mercury, and selenium concentrations. Environ Res. 2002 Sep;90(1):47-60. PubMed PMID: 12359190.

71: Kappus H, Reinhold C. Heavy metal-induced cytotoxicity to cultured human epidermal keratinocytes and effects of antioxidants. Toxicol Lett. 1994 Apr;71(2):105-9. PubMed PMID: 8171440.

72: Lukacínová A, Rácz O, Lovásová E, Ništiar F. Effect of lifetime low dose exposure to heavy metals on selected serum proteins of Wistar rats during three subsequent generations. Ecotoxicol Environ Saf. 2011 Sep;74(6):1747-55. doi: 10.1016/j.ecoenv.2011.04.017. Epub 2011 May 6. PubMed PMID: 21549428.

73: Ognjanovic BI, Markovic SD, Pavlovic SZ, Zikic RV, Stajn AS, Saicic ZS. Effect of chronic cadmium exposure on antioxidant defense system in some tissues of rats: protective effect of selenium. Physiol Res. 2008;57(3):403-11. Epub 2007 Apr 25. PubMed PMID: 17465690.

74: Suzuki N, Yamamoto M, Watanabe K, Kambegawa A, Hattori A. Both mercury and cadmium directly influence calcium homeostasis resulting from the suppression of scale bone cells: the scale is a good model for the evaluation of heavy metals in bone metabolism. J Bone Miner Metab. 2004;22(5):439-46. PubMed PMID: 15316864.

75: Benkoel L, Dodero F, Roussel E, Baudin JC, Lambert R, Chamlian A, Augier H. Hepatotoxic effect of metallic pollutants on enzyme histochemical activities of yellow-legged gull Larus cachinnans michahellis liver. Cell Mol Biol (Noisy-le-grand). 2000 Nov;46(7):1183-9. PubMed PMID: 11075948.

76: Yamamoto C. [Toxicity of cadmium and lead on vascular cells that regulate fibrinolysis]. Yakugaku Zasshi. 2000 May;120(5):463-73. Review. Japanese. PubMed PMID: 10825810.

77: Costa A, Branca V, Minoia C, Pigatto PD, Guzzi G. Heavy metals exposure and electromagnetic hypersensitivity. Sci Total Environ. 2010 Sep 15;408(20):4919-20; author reply 4921. doi: 10.1016/j.scitotenv.2010.06.045. PubMed PMID: 20643474.

78: Moon SS. Association of lead, mercury and cadmium with diabetes in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. Diabet Med. 2013 Apr;30(4):e143-8. doi: 10.1111/dme.12103. PubMed PMID: 23278294.

79: Wilks MF, Kwizera EN, Bach PH. Assessment of heavy metal nephrotoxicity in vitro using isolated rat glomeruli and proximal tubular fragments. Ren Physiol Biochem. 1990 Sep-Oct;13(5):275-84. PubMed PMID: 1697089.

80: Rehwoldt R, Menapace LW, Nerrie B, Alessandrello D. The effect of increased temperature upon the acute toxicity of some heavy metal ions. Bull Environ Contam Toxicol. 1972 Aug;8(2):91-6. PubMed PMID: 5077496.

81: Liu J, Qu W, Kadiiska MB. Role of oxidative stress in cadmium toxicity and carcinogenesis. Toxicol Appl Pharmacol. 2009 Aug 1;238(3):209-14. doi: 10.1016/j.taap.2009.01.029. Epub 2009 Feb 21. Review. PubMed PMID: 19236887.

82: Boujbiha MA, Hamden K, Guermazi F, Bouslama A, Omezzine A, Kammoun A, El Feki A. Testicular toxicity in mercuric chloride treated rats: association with oxidative stress. Reprod Toxicol. 2009 Jul;28(1):81-9. doi: 10.1016/j.reprotox.2009.03.011. Epub 2009 Apr 5. PubMed PMID: 19427169.

83: Satarug S, Nishijo M, Lasker JM, Edwards RJ, Moore MR. Kidney dysfunction and hypertension: role for cadmium, p450 and heme oxygenases? Tohoku J Exp Med. 2006 Mar;208(3):179-202. Review. PubMed PMID: 16498227.

84: Markovich D, James KM. Heavy metals mercury, cadmium, and chromium inhibit the activity of the mammalian liver and kidney sulfate transporter sat-1. Toxicol Appl Pharmacol. 1999 Jan 15;154(2):181-7. PubMed PMID: 9925802.

85: Goldberg RL, Kaplan SR, Fuller GC. Effect of heavy metals on human rheumatoid synovial cell proliferation and collagen synthesis. Biochem Pharmacol. 1983 Sep 15;32(18):2763-6. PubMed PMID: 6626246.

86: Chisolm JC, Handorf CR. Zinc, cadmium, metallothionein, and progesterone: do they participate in the etiology of pregnancy induced hypertension? Med Hypotheses. 1985 Jul;17(3):231-42. PubMed PMID: 3900651.

87: Virtanen JK, Rissanen TH, Voutilainen S, Tuomainen TP. Mercury as a risk factor for cardiovascular diseases. J Nutr Biochem. 2007 Feb;18(2):75-85. Epub 2006 Jun 16. Review. PubMed PMID: 16781863.

88: Mordukhovich I, Wright RO, Hu H, Amarasiriwardena C, Baccarelli A, Litonjua A, Sparrow D, Vokonas P, Schwartz J. Associations of toenail arsenic, cadmium, mercury, manganese, and lead with blood pressure in the normative aging study. Environ Health Perspect. 2012 Jan;120(1):98-104. doi: 10.1289/ehp.1002805. Epub 2011 Aug 30. PubMed PMID: 21878420; PubMed Central PMCID: PMC3261928.

89: Kim DS, Lee EH, Yu SD, Cha JH, Ahn SC. [Heavy metal as risk factor of cardiovascular disease–an analysis of blood lead and urinary mercury]. J Prev Med Public Health. 2005 Nov;38(4):401-7. Korean. PubMed PMID: 16358824.

90: Skerfving S. Heavy metal toxicology. Appl Radiat Isot. 1998 May-Jun;49(5-6):697. PubMed PMID: 9606088.

91: Pier SM. The role of heavy metals in human health. Tex Rep Biol Med. 1975;33(1):85-106. Review. PubMed PMID: 171792.

92: Razinger J, Dermastia M, Koce JD, Zrimec A. Oxidative stress in duckweed(Lemna minor L.) caused by short-term cadmium exposure. Environ Pollut. 2008 Jun;153(3):687- Epub 2007 Sep 27. PubMed PMID: 17900769.

Ozone Therapy Scientific References:

1. Wolff HH. Die behandlung peripherer durchblutungsstorungen mit ozon. Erfahr Hk 1974;23:181–184. 2. Bocci V, Paulesu L. Studies on the biological effects of ozone: Haematologica 1990;75:510–515. 3. Bocci V, Luzzi E, Corradeschi F, Paulesu L, Di Stefano A. Studies on the biological effects of ozone: Lymphokine Cytokine Res 1993;12: 121–126. 4. Bocci V, Luzzi E, Corradeschi F, Paulesu L, Rossi R, Cardaioli E, et al. Studies on the biological effects of ozone: Cytokine production and glutathione levels in human erythrocytes. J Biol Regulat Homeost Agent 1993;7:133–138. 5. Bocci V, Luzzi E, Corradeschi F. Studies on the biological effects of ozone: Evaluation of immunological parameters and tolerability in normal volunteers receiving ambulatory autohaemotherapy. Biotherapy 1994;7:83–90. 6. Bocci V, Valacchi G, Corradeschi F, Aldinucci C, Silvestri S, Paccagnini E, et al. Studies on the biological effects of ozone: Generation of reactive oxygen species (ROS) after exposure of human blood to ozone. J Biol Regulat Homeost Agent 1998;12:67–75. 7. Bocci V, Valacchi G, Corradeschi F, Fanetti G. Studies on the biological effects of ozone: Effects on the total antioxidant status and on interleukin-8 production. Mediat Inflamm 1998;7:313–317. 8. Bocci V, Valacchi G, Rossi R, Giustarini D, Paccagnini E, Pucci AM, et al. Studies on the biological effects of ozone: 9. Effects of ozone on human platelets. Platelets 1999;10:110–116. 9. Bocci V. Ossigeno-ozono terapia, Comprensione dei meccanismi di azione. Milano: Casa Editrice Ambrosiana;2000. 10. Bocci V. Oxygen-Ozone Therapy. A critical evaluation. Dordrecht, The Netherlands: Kluwer Academic Publishers;2002. 11. Bocci V. OZONE. A New Medical Drug. Dordrecht, The Netherlands: Springer;2005. 12. Pryor WA, Squadrito GL, Friedman M. The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic Biol Med 1995;19:935–941. 13. Halliwell B, Clement MV, Long LH. Hydrogen peroxide in the human body. FEBS Lett 2000;486:10–13. 14. Bocci V, Aldinucci C, Bianchi L. The use of hydrogen peroxide as a medical drug. Riv Ital Ossigeno Ozonoterapia 2005;4:30–39. 15. Valacchi G, Bocci V. Studies on the biological effects of ozone: 11. Release of factors from human endothelial cells. Mediat Inflamm 2000;9:271–276. 16. Dianzani MU. 4-Hydroxynonenal and cell signalling. Free Radic Res 1998;28:553–560. 17. Iles KE, Liu R-M. Mechanisms of glutamate cysteine ligase (GCL) induction by 4-hydroxynonenal. Free Radic Biol Med 2005;38: 547–556. 18. Snyder SH, Baranano DE. Heme oxygenase: a font of multiple messengers. Neuropsychopharmacology 2001;5:294–298. 19. Wollert KC, Drexler H. Clinical application of stem cells for the heart. Circ Res 2005;96:151–163. 20. Mendiratta S, Qu Z-C, May JM. Erythrocyte ascorbate recycling: antioxidant effects in blood. Free Radic Biol Med 1998;24:789–797. 21. Stone JR, Collins T. The role of hydrogen peroxide in endothelial proliferative responses. Endothelium 2002;9:231–238. 22. BocciV.Areasonable approach for the treatment of HIVinfection in the early phase with ozone therapy (autohemotherapy). How inflammatory cytokines may have a therapeutic role. Mediat Inflamm 1994; 3:315–321. 23. Bocci V. Autohaemotherapy after treatment of blood with ozone. A reappraisal. J Intern Med Res 1994;22:131–144. 24. Baeuerle PA, Henkel T. Function and activation of NF-kB in the immune system. Annu Rev Immunol 1994;12:141–179. 25. Bocci V. Roles of interferon produced in physiological conditions. A speculative review. Immunology 1988;64:1–9. 26. Valacchi G, Bocci V. Studies on the biological effects of ozone: 10: Release of factors from ozonated human platelets. Mediat Inflamm 1999;8:205–209. 27. Frehm EJ, Bonaventura J, Gow AJ. S-nitrosohemoglobin: an allosteric mediator of NO group function in mammalian vasculature. Free Radic Biol Med 2004;37:442–453. 28. Goldman M. Cancer risk of low-level exposure. Science 1996;271: 1821–1822.434 Bocci/ Archives of Medical Research 37 (2006) 425–435 29. Calabrese EJ, Baldwin LA. Hormesis: U-shaped dose responses and their centrality in toxicology. Trends Pharmacol Sci 2001;22:285–291. 30. Bocci V. Does ozone therapy normalize the cellular redox balance? Med Hypotheses 1996;46:150–154. 31. Sharma YK, Davis KR. The effects of ozone on antioxidant responses in plants. Free Radic Biol Med 1997;23:480–488. 32. Leon OS, Menendez S, Merino N, Castillo R, Sam S, Perez, et al. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Med Inflamm 1998;7:289–294. 33. Barber E, Menendez S, Leon OS, Barber MO, Merino N, Calunga JL, et al. Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia. Mediat Inflamm 1999;8:37–41. 34. Larini A, Bianchi L, Bocci V. The ozone tolerance: I. Enhancement of antioxidant enzymes is ozone dose-dependent in Jurkat cells. Free Radic Res 2003;37:1163–1168. 35. Bocci V, Borrelli E, Valacchi G, Luzzi E. Quasi-total body exposure to an oxygen-ozone mixture in a sauna cabin. Eur J Appl Physiol 1999; 80:549–554. 36. Bocci V, Di Paolo N. Oxygenation-ozonation of blood during extracorporeal circulation (EBOO). III. A new medical approach, ozone. Science 2004;26:195–205. 37. Garber GE, Cameron DW, Hawley-Foss N, Greenway D, Shannon ME. The use of ozone-treated blood in the therapy of HIV infection and immune disease: a pilot study of safety and efficacy. AIDS 1991;5:981–984. 38. Cooke ED, Pockley AG, Tucker AT, Kirby JDT, Bolton AE. Treatment of severe Raynaud’s syndrome by injection of autologous blood pretreated by heating, ozonation and exposure to ultraviolet light (H-O-U) therapy. Int Angiol 1997;16:250–254. 39. Torre-Amione G, Sestier F, Radovancevic B, Young J. Effects of a novel immune modulation therapy in patients with advanced chronic heart failure. J Am Coll Cardiol 2004;44:1181–1186. 40. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-b, PGE 2 and PAF. J Clin Invest 1998;101:890–898. 41. Tremblay J, Chen H, Peng J, Kunes J, Vu MD, Sarkissian SD, et al. Renal ischemia-reperfusion injury in the rat is prevented by a novel immune modulation therapy. Transplantation 2002;74:1425–1433. 42. Tylicki L, Niew GT, Biedunkiewicz B, Burakowski S, Rutkowski B. Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs. Int J Artif Organs 2001;24:79–82. 43. Clavo B, Perez JL, Lopez L, Suarez G, Lloret M, Rodriguez V, et al. Effect of ozone therapy on muscle oxygenation. J Altern Compl Med 2003;9:251–256. 44. Biedunkiewicz B, Tylicki L, Niewegloski T, Burakoski S, Rutkowski B. Clinical efficacy of ozonated autohemotherapy in hemodialyzed patients with intermittent claudication: an oxygen-controlled study. Int J Artif Organs 2004;27:29–34. 45. De Monte A, van der Zee H, Bocci V. Major ozonated autohemotherapy in chronic limb ischemia with ulcerations. J Alt Compl Med 2005; 11:363–367. 46. Chan WM, Lam DS, Wong TH, Lai TY, Kwok AK, Tam BS, et al. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series. Ophthalmology 2003;110:2395–2402. 47. The AMDRT Research Group. The age-related macular degeneration radiotherapy trial (AMDRT): one year results from a pilot study. Am J Ophthalmol 2004;138:818–828. 48. Gragoudas ES, Adamis AP, Cunningham ET, Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805–2816. 49. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271–2284. 50. BarnesPJ. Scientificrationale for inhaledcombination therapywithlongacting b2-agonists and corticosteroids. Eur Respir J 2002;19:182–191. 51. Barnes PJ, Liew FY. Nitric oxide and asthmatic inflammation. Immunol Today 1995;16:128–130. 52. Stamler JS. S-nitrosothiols in the blood: roles, amounts and method of analysis. Circ Res 2004;94:414–417. 53. Lipsky BA. Medical treatment of diabetic foot infections. Clin Infect Dis 2004;39:S104–S114. 54. Bocci V, Larini A, Micheli V. Restoration of normoxia by ozone therapy control neoplastic growth: a review and a working hypothesis. J Alt Compl Med 2005;11:257–265. 55. Gonzalez R, Borrego A, Zamora Z, Romay C, Hernandez F, Menendez S, et al. Reversion by ozone treatment of acute nephrotoxicity induced by cisplatin in rats. Med Inflamm 2004;13:307–312. 56. Andreula CF, Simonetti L, De Santis F, Agati R, Ricci R, Leonardi M. Minimally invasive oxygen-ozone therapy for lumbar disk herniation. Am J Neuroradiol 2003;24:996–1000. 57. Baysan A, Whiley RA, Lynch E. Antimicrobial effect of a novel ozone-generating device on micro-organisms associated with primary root carious lesions in vitro. Caries Res 2000;34:498–501. 58. Cianci P. Advances in the treatment of the diabetic foot: is there a role for adjunctive hyperbaric oxygen therapy?Wound Repair Regen 2004; 12:2–10. 59. Gill AL, Bell CN. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. Q J Med 2004;97:385–395. 60. Goldstein BD, Balchum OJ. Effect of ozone on lipid peroxidation in the red blood cell. Proc Soc Exp Biol Med 1967;126:356–359. 61. Couzin J, Kaiser J. As Gelsinger case ends, gene therapy suffers another blow. Science 2005;307:1028. 62. Maxwell SRJ, Webb DJ. COX-2 selective inhibitors-important lessons learned. Lancet 2005;365:449–451. 63. Beardsley S. Avoiding another VIOXX. Sci Am 2005;292:9–10. 64. Babior BM, Takeuchi C, Ruedi J, Gutierrez A, Wentworth P Jr. Investigating antibody-catalyzed ozone generation by human neutrophils. Proc Natl Acad Sci USA 2003;100:3031–3034. Ozone Therapy Today 435 65. Akulich II, Tafintsev AI Vlasov , LA, NA Miroshnichenko Conservative treatment of chronic tonsillitis using drugs ozone / / Mater.IV Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.39 -40. 66. Alekhine SP The effectiveness of ozone therapy in obliterating atherosclerosis of the arteries of the lower extremities . Diss .. Candidate of medical sciences . . Nizhny Novgorod , 1999 . 67. Anisimov VN, Grechko, VN Borisov DL Experience of treatment with ozone frozen shoulder and shoulder epicondylitis / / Mater.IV Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.48 . 68. Artyuhin AA, Zuev , VM, Jibladze TA, Alexandrov LS Ozone therapy chronically urethritis / / Mater . II All-Russian scientific- practical conference “Ozone in biology and medicine .” . Nizhny Novgorod . . 1995 . . P.49 -50. 69 . Atyasov NI, Gazin , IA Ozonated saline solution in the complex treatment of metabolic disorders in patients with decompensated diabetes mellitus / / Mater.IV Russian scientific-practical conference “Ozone and methods effec -tive therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.93 -94 . 70. Belyaev AN Atyasov NI, EA Rygin etc. The use of ozone in the treatment of complex complicated diabetic angiopathy of lower limbs / / Mater.IV Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.95 . 71. Bolgov VF Gribkova IA, Maslennikov, OV Ozone therapy in obliterating atherosclerosis of lower – limb present / / Mater.IV Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.87 -88 . 72. Botwin MA, Pobedinskii NM, V. Zuev etc. The use of ozone for the prevention of inflammatory diseases after myomectomy / / Mater . II All-Russian scientific- practical conference “Ozone in biology and medicine .” . Nizhny Novgorod . . 1995 . . P.61 . 73. Boyarinov GA, Zhitenev SB Gurevich , VV Ozone therapy in treatment of chronic prostatitis / / Mater.IV Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 2000 . 74 . Bulls AT, EI Sychev , Mumdzhyan AG The application of oil ” ozonide ” in the complex treatment of erosive processes nom cervical / / Mater . III All-Russian scientific- practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 1998 . . P.58 -59 . 75. Wexler NO The use of sodium hypochlorite and ozonated physiological strength solution in complex intensive therapy in patients with infective endo- carditis . Diss .. Candidate of medical sciences . . Moscow, 1998 . 76. Wexler NY, Sitnova NL, TA Germanova Ozone and others in the complex de – intoxication in patients with complicated forms of acute pneumonia / / Mater.IV Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.61 -62 . 77. Veretelnikov Y. , rings VS The use of ozonated solutions in the complex treatment of odontogenic abscesses maxillofacial / / Mater . III All-Russian scientific- practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 1998 . . P.98 . 78. Winnick YS, Yakimov SV, OV Apishina , Yakimova VB The use of ozonated saline -tion with bailouts of the abdominal cavity in patients Opera Rowan about pancreatic necrosis / / Mater.IV Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” Nizhny Novgorod . . 2000 . . P.77 -78 . 79. Gazin IK Ozone therapy necrotic lesions of the foot in patients with diabetes mellitus / / Mater.IV Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.97 -98 . 80. Glavinskaya TA, OA Ivanov , VD Komarov Immune status with ozone therapy in patients with neurodermatitis / / Mater . II All-Russian scientific -practical conference “Ozone in biology and medicine .” . Nizhny Novgorod . . 1995 . . P.85 . 81. S. Gorbunov Ozone treatment of arthritis and arthrosis / / Mater . II Russian of scientific and practical conference “Ozone in biology and medicine .” . Nizhny Novgorod . 82. Grechkanev GO The scientific rationale for the use of medical ozone in the complex treatment of Mr. miscarriage . Diss .. Candidate of medical sciences . . Ivanovo , 1995 . 83. Grechko , VN The use of ozone in the complex treatment of patients with E – deforming arthrosis of large joints / / Mater.IV Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.49 -50. 84. Gustov A. Kotov, SA, Kontorshikova KN, Potekhina UP Ozone therapy in nev – meteorology . . Nizhny Novgorod : ” Letter “. . 1999 . . 179 p. 85. Durnovos EA Rationale for the use of ozone in the complex treatment of the face and neck abscesses . Diss .. Candidate of medical sciences . . Moscow, 1998 . 86. Zawadzki VN, Glazyrina EV Ozone therapy for alopecia areata / / Mater . II All-Russian scientific- practical conference “Ozone in biology and medicine .” . Nizhny Novgorod . 87. Zaitsev AB The complex surgical treatment of patients with chronic osteo- myelitis leg. Diss .. Candidate of medical sciences . . Nizhny Novgorod , 1998 . 88. Zmyzgova AV Isaev NP, Kulikov EA etc. Experience with chronic ozone in the complex treatment of chronic hepatitis / / Mater . III All-Russian scientific- practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 1998 . . P.108- 109. 89. V. Zuev Some of the pathogenesis , diagnosis and comprehensive treatment of women with inflammatory processes and benign neoplasms -mi of the reproductive system . Diss .. Dr. med . . Moscow, 1998 . 90. Zhahbarov AG Ozone therapy and hyperbaric oxygen therapy in the com – plex treatment of patients with acute odontogenic inflammatory processes of the maxillofacial region. Diss .. Candidate of medical sciences . . Almaty , 1998 . 91. Karataev SD Ozone therapy helikobaktezavisimyh diseases. Diss .. Doctor . med . . Moscow, 2000 . 92. Knoh HG , Klug B. The ozone- oxygen therapy in proctology / / Terapevt.arh . . 1990 . . T.68 . – ? 2 . . S. 93-98 . 93. Kolesov OE, IT Vasiliev , GV Leonteva Ozone and other peritonitis ( of methodical recommendations ) . . M. , 1995 . . 21 . 94 . Komshalyuk MS, VA Maksimov , Vinarova SI and others in the ozonation treatment of chronic liver disease / / Mater . III All-Russian scientific- practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 1998 . . S. 108. 95. Kotov , SA Clinical and experimental justification of the use of intravenous infusions of ozonated saline solution in the complex treatment of patients with suprasegmental autonomic disorders . Diss .. Candidate of medical sciences . . Nizhny Novgorod , 1996 . 96. Kotov , SA Clinical and neurophysiological rationale for ozone therapy , nerve diseases dimensional system. . Diss .. Doctor . med . . Ivanovo , 2000 97. Koshelev IV, Ivanov OL, Kulikov AG The use of different methodologies ozonotera -tropy with eczema / / Proc. scientific papers SMU “Chronic dermatitis : new aspects of pathogenesis and therapy.” . Moscow, 2000 . . S. 56. 98. Krivatkin SL, Krivatkina EV Ozone therapy of skin diseases / / Mater . III All – Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 1998 . . S. 125-127 . 99. Kuznetsov NA, Rodoman GV, Laberko LA Ozone and others in the complex treatment of venous leg ulcers of venous etiology / / Mater.IV Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.88 -89 . 100. Kulikov AG, Sherbina TM The use of ozone in the treatment of patients with gastro -duodenal disease and diabetes mellitus / / Mater . 1 n – Russian Congress of rontologov and geriatricians . . Samara . . 1999 . . P.192 -193 . 101. Kulikov AG, OM Kiselev The use of ozone therapy in diabetic – time zheniyah eye / / Proceedings of the II International Congress on Health Resort . . Moscow, 2000 . – P.73 102. Kuncevich LD, Borschevskaya RP, Mishanov VR, Ivanov OA Small – autogemoozo monotherapy in treatment of women with chronic gonorrhea / / Ma – ter. III All-Russian scientific- practical conference “Ozone and methods effec -tive therapy in medicine .” . Nizhny Novgorod . . 1998 . . P.127 -128 . 103. Lelyanov AD, Kasumyan SA, Sergienko VI, Sokolowski SA The role of physico -chemical and biological methods in treatment of acute peritonitis spread nennogo / / Mater.IV Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.78 -79 . 104. Maximov V. Chernyshev, AL, SD Karataev Ozone therapy . . M. : 1998. . 14c . 105. Oleg Maslennikov , Kontorshikova KN Ozone therapy . Internal Medicine ( Pozo beats ) . . Nizhny Novgorod : Publishing House of the NGMA , 1999 . . 55 . 106 Maslennikov , OV, SV Andosov , fungal, IA, Eremina LN Ozone therapy in internal medicine / / Mater.IV Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.43 -44 . 107. Mizurov NA The use of intra-arterial and intravenous ozone therapy in the complex treatment of patients with diabetic lesions of the lower limbs , complicated by purulent necrotic lesions . Ph.D. diss .. . med . . Saransk , 1998 . 108. Mironov ZS, Mironov SP, LA Sibel’din Ozone and other patients with various forms of degenerative joint damage / / Mater . III All-Russian scientific- practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 1998 . . P.83 -84 . 109. Moshura IP, VP Glyantsev Ozone therapy of inflammatory diseases in patients with diabetes mellitus / / Mater . III All-Russian Scientific and Practical Conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 1998 . . P.106 . 110. Pavlovian EE Ozone therapy of diabetes. Dis .. Candidate of medical sciences . . Nizhny Novgorod , 1998 . 111.. Pestles SV, VA Maksimov , Karataev SD, Chernyshev , AL Topical application of ozonated saline solution in the treatment of patients with acute and chronic purulent sinusitis cal / / Mater . III All-Russian Scientific and Practical Conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod .1998 . . P.92 -93 . 112. Pobedinskii NM, Zuev , VM, TA Jibladze etc. Ozone therapy in gynecological practice tion / / Guidelines . Moscow, 1992 . 113. Razvalyaeva OV The influence of ozone therapy on lipid peroxidation in patients with chronic diffuse liver disease. . Ph.D. diss .. . med . . Volgograd . .1997 . . 24c . 114. Semenov , SV, Snigorenko AS, Kudryavtsev BP Ozone therapy is the general peritonitis / / Mater.IV Russian scientific-practical conference “Ozone and methods effec -tive therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.72 -73 . 115. Coulter A. The influence of ozone on health during pregnancy and childbirth in women with constitutional exogenous obesity. Diss .. kand.med . Science. . Nizhny Novgorod 116 Pods P., A. Zubkov , Zolkina IV, Kulikov AG On the use of ozone therapy in the treatment of respiratory diseases / / All- Mater.IV of scientific and practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.60 -61 . 117. EI Sychev Ozone therapy in complex sanatorium treatment of patients with ischemic heart disease in the resort of Sochi. . Thesis for Candidate of medical sciences .. .. . Nizhny Novgorod , 2000 . 118. Terentyeva AB Ozone therapy in acute and chronic purulent inflammation of the maxillary sinuses. Diss .. Candidate of medical sciences . . Samara , 1999 . 119. Usachova ON The scientific rationale for the use of medical ozone in the complex therapy of OPG . toxaemia . Diss.kand.med.nauk . . Nizhny Novgorod , 1996 . 120. Chuprunova IN, Livshits JN, LM Lukinykh Ozone in the treatment of diseases of steam Dont / / Mater . III All-Russian scientific- practical conference “Ozone and meth-ods of efferent therapy in medicine .” . Nizhny Novgorod . . 1998 . . P.133 . 121. Shakutin MK Clinical evaluation of the method of ozone therapy in treatment of iron deficiency anemia in pregnancy and prevention of placental insufficiency. Diss .. Candidate of medical sciences . – Nizhny Novgorod , 1995 . 122. Shahs AV, AB Terentyeva The use of ozone therapy in patients who had undergone surgery for cancer of the larynx / / Mater . II All-Russian scientific- practical conference “Ozone in biology and medicine .” . Nizhny Novgorod . . 1995 . . P.44 . 123. Yadav , NM The use of medical ozone in the complex treatment of acute ones -tion of inflammatory diseases of the internal reproductive organs of women. Diss .. kandmed.nauk . . Ivanovo , 1996 . 124. AN Edeleva Clinical and experimental justification for the use of ozone in the treatment of patients with chronic suppurative mesotympanitis . Diss .. Candidate of medical sciences . . Nizhny Novgorod , 1999 . 125. Yakovlev, AB, gorgeous – Yadzy M. Yousuf , M. et al Clinical experience outside of application of organic ozonides for the treatment of various skin diseases and its appendages / / Mater . II All-Russian scientific- practical conference “Ozone in biology and medicine .” . Nizhny Novgorod . . 1995 . . P.88 -89 . 126. Yakovlev AY, Brichkin JD, AN Fufaev and other methods ozonote effectiveness of therapy in the treatment of acute viral hepatitis / / Mater.IV Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.81 . 127. Yakovlev AY, Brichkin JD, Shalapuda VI etc. The use of ozone therapy in the treatment of respiratory diseases / / Mater.IV Russian scientific-practical conference “Ozone and methods of efferent therapy in medicine .” . Nizhny Novgorod . . 2000 . . P.63 . 128. Richelmi P., Frazini M., Valdenassi L. Ossigeno-ozono terapia. / Pavia bergamo. . 1995 . 129. Rilling S. The basis clinical application of ozone therapy / / Ozonachrichten. 1985 . – ? 4 . . P.7- 17. 130. Rilling S., Viebahn R. The Use of Ozone in Medicine. New York: Haug. . 1987 . 131. Viebahn-Haensler R. The use of ozone in medicine. Heidelberg, Germany. 1998 . 148 p. 132. Wolff H.H. Das medizinische Ozon / / 2 Aufl. Verlag fur Medizin. – Heidelberg. . 1982 . 133. Alekhine , SP Ozone Therapy : Clinical and Experimental Aspects / SP Alekhine , TG Shcherbatyuk . – N. Novgorod: Letter , 2003 . – 240 . 615.83 A -491 Ab / Scientific 134. Alyasova , AV Diseases of the breast . Prevention and treatment / A. Alyasova . – M.: Tsentrpoligraf , 2005 . – 189 p. 618 A -608 Ab / scientific * 135. Alyasova , AV Ozone technology in the treatment of malignant tumors / AV Alyasova , KN Kontorshikova , BE Checks. – N. Novgorod: NGMA , 2006 . – 204 p . 616-006 A -608 Ab / scientific * 136. Bezrukov , IV Ozone therapy in periodontal practice / IV Bezrukov , NB Petrukhina . – Moscow: Medical Information Agency, 2008 . – 88 p. 616.31 B -405 B / s 137. Gustov , AV Ozone therapy in neurology : monograph / AV Gustov , KN Kontorshikova , JP Potekhina . – 3rd ed. , Ext . and rev. – Nizhny Novgorod : NizhGMA , 2012. – 192 p . 616.8 F -967 138. Dynamics of some parameters of hemostasis in pregnant women with chronic placental insufficiency (compensated form) under the influence of ozone therapy and HBO / HM Clemente Apumayta [etc. ] / / Actual problems of population health management / under total. Ed. IA Kamaeva . – Nizhny Novgorod : BI , 2010 . – S. 39-41 . 614.2 A -437 Ab 139. Ivanov , EM Ozone therapy in geriatrics : monograph / EM Ivanov, O. Kytikova , AD Novgorod. – Vladivostok : Far Eastern University, 2006 . – 256 p. 615.83 I- 202 Ab / 140. Kazarina , LN Ozone and girudoterapiya in treatment glossalgia : Tutorial / L. Kazarina , AI Volozhin . – Nizhny Novgorod : NGMA , 2002 . – 48 . 616.31 K- 143 Ab / 141. Kachalina , TS Ozone technology in obstetrics and gynecology / TS Kachalina , GO Grechkanev . – Nizhny Novgorod : NGMA , 2007 . – 292 p. 618 TO -309 W / h 142 . Clinical Transfusiology in obstetrics , gynecology and neonatology / O. Rogachevskiy [ et al.] – Moscow: Triad -X, 2001 . – 331 . 615.38 K-493 Ab / Scientific 143. Conservative treatment of nonhealing wounds festering in trauma and orthopedic patients with ozone and Poviargol : A Guide for Physicians / comp . AM Gnetnev [ et al.] – Saratov: Saratov Scientific Research Institute of Traumatology and Orthopedics , 2000 . – 10 . 616-001 K-65 Ab / Scientific 144. Correction of homeostasis in acute pancreatitis by ozone therapy / MI Gulman [ et al.] – Atlanta: BI , 2003 . – 179 p. 616.37 K- 629 Ab / scientific * 145. Maksimov, VA Ozone Therapy / VA Maksimov, AL Chernyshev , SD Karataev . – M: BI , 1998 . – 15 . 615.83 M -171 Ab / scientific * 146. Maslennikov , OV Ozone therapy . Internal Medicine / O. Maslennikov , KN Kontorshikova . – Nizhny Novgorod : Vector – TiS, 2003 . – 132 . 616 M -315 Ab / Scientific 147. Maslennikov , OV Practical ozone / O. Maslennikov , KN Kontorshikova . – N. Novgorod: The vector- TiS , 2003 . – 52 . 615.83 M -315 Ab / scientific * 148. Maslennikov , OV Guidelines for ozone therapy / O. Maslennikov , KN Kontorshikova , IA Gribkova . – 2nd ed . , Rev. and additional .. – Nizhny Novgorod : Vector – TiS, 2008 . – 326 p. 615.83 M -314 Ab / scientific * 149. Medical ozone in the treatment of obstetric and gynecologic pathology : A Guide for Physicians / comp . NY Katkov [ et al.] – Nizhny Novgorod : NGMA , 2001 . – 16 . 618 150. Ozone Therapy / Ch. Ed. VV Shkarin . – Nizhny Novgorod : NGMA , 2005 . – 250

Laser Medicine Scientific References:

1. Clinical applications of Laser Medicine: Republican collection of papers / Min. Ed. GS Leskin, MT Alexandrov, Ed. Organization of the Moscow Regional Clinical Research Institute. MF Vladimir’s. – M. Monique, 1990. – 112. 615.8 A-437 W / o
2. Emirs, N. B. Diagnosis and comprehensive drug-laser therapy of pneumonia / h. B. Amirov, AA Wiesel. – Kazan: Medicine, 2002. – 108. 616.2 A-62 Ab /
3. Amirkhanian, AN Laser therapy in dentistry / AN Amirkhanian, VA Buylin, SV Moskvin. – M. : Triad, Tver: Triad, 2007. – 32. 616.31 A-62 Ab / *
4. Brekhov, EI Theory and practice of EHF-therapy laser / EI Brekhov, VA Buylin, SV Moskvin. – M. : Triad, Tver: Triad, 2007. – 160. 615.8 B-877 B / s
5.Brill, GE Molecular and cellular basis for the therapeutic effect of low-intensity laser radiation in chebnoe manual / GE Brill. – Saratov: SMU, 2000. – 42. 612 B-879 Ab / *
6. Volkov, SV Chemical burns of the esophagus and stomach (e ndoskopicheskaya diagnosis and laser therapy) / S. Volkov, A. Ermoloff, EA Luzhniki. – M. : Medical practice, Moscow, 2005. – 120. 616.3 B-676 B / s
7.Geynits, AV Intravenous laser irradiation of blood / AV Geynits, SV Moskvin, GA Aziz. – M. : Triad, Tver: Triad, 2006. – 144. 616.15 D-296
8. Damirov, M. M. Radiowave, cryogenic and laser technologies in diagnosis and treatment in gynecology / M. M. Damirov. – M. : BINOM, 2011. – 320. 618 W-162 W / h
9. Ermuhambetov, TK Laser radiation in the treatment of asthma / TK Ermuhambetov. – Alma-Ata: BI, 1984. – 48. 616.2 E-749
10. Zhukov, BN Laser Technologies in Medicine: onografiya m / BN Zhukov, NA Lisov, VI Anisimov. – Samara: Samara State Medical University, 2001. – 223 p. 615.8 F-86 B / s
11.Ziryanov, BN Low-intensity laser therapy in oncology / BN Ziryanov, VA Yevtushenko, ZD Kitsmanyuk. – Tomsk: STT, 1998. – 336. 616-006 W-976 Ab / *
12. Ivanov, AS Guide to laser dental diseases / A. Ivanov. – St. Petersburg. : SPbGMA, 2000. – 69. 616.31 I-2
13. Ivanchenko, LP Laser therapy in urology / LP Ivanchenko, AS Kozdoba, SV Moskvin. – M. : Triad, 2009. – 132. 616.6 I-231 Ab / , c / o
14. The use of lasers in cardiovascular surgery: from experiment to practice / EN Pavlyukova [Etc.], Siberian State Medical University. – Tomsk: STT, 2010. – 238. 616.1 I-883 W / h
15. Kochetkov, AV Laser therapy of patients with cerebral stroke: a guide for physicians / AV Kochetkov, 16. SV Moskvin. – M. : Triad, Tver: Triad, 2004. – 51. 616.8 K-756
17. Koshelev, In. H. Laser in abdominal surgery: a monograph / In. H. Koshelev, SW. B. Chalyk. – Saratov: Sarat in. University Press, 1985. – 160. 617.5 K-765 Ab / h science, W / o
18. Koshelev, In. H. Laser oterapiya gastroduodenal ulcers / In. H. Koshelev. – Saratov: Sarat in ovskogo University, 1980. – 74. 616.3 K-76 Ab /
19. Laser therapy in pediatrics: monograph / SV Moskvin, AN Nasedkin, AJ Osin, MA Khan. – M. : Triad, Tver: Triad, 200 9. – 480. 615.8 L-175 Ab / , c / o
20.Laser therapy in complex treatment of patients with stable angina: Tool / LY The Queen, N. Boars, M. T. Saltseva, NV Amineva, EO Obukhov Nizhny Novgorod State Medical Academy, Nizhny Novgorod Oblast Clinical Hospital. NA Semashko. – Nizhniy Novgorod: NGMA, 1997. – 36. 616.1 L-175 Ab / , c / o
21.Laser treatment of diseases of the genitourinary areas: teaching and methodical collection / SV Moskvin, ML Mufaged, VA Buylin, M. B. Lutoshkin, IO Lipatov, LP Ivanchenko. – M. : Triad, 2004. – 160. 616.6 L-175 Ab / *
22.Laser radiation in the treatment of patients with diseases and burns gnoynosepticheskimi: manual / PI Thick, AN Ivanyan, LI Gerasimov, VA Derbenyov, MA Sopromadze. – M. : BI, 1994. – 88 p. 616 L-175 Ab /
23.Lasers in endoscopy / NE Chernehovskaya, AV Geynits, OV Lovacheva, AV Povalyaev. – M. : MEDpress-Inform, 2011. – 144. 615.8 L-175 W / h
Moskvin, S. Intravenous laser irradiation of blood / SV Moskvin, GA Aziz. – M. : NPLTS “Technique”, 2003. – 32. 615.8 M-822 Ab / *
24.Moskvin, S. Laser-vacuum massage / SV Moskvin, NA Ghorbani. – M. : Triad, Tver: Triad, 2006. – 72. 615.82 M-822 Ab / *
25. Moskvin, S. Basics of laser therapy / S. Moskvin, VA Buylin. – M. : Triad, Tver: Triad, 2006. – 256 p. 615.8 M-822 W / h
26.Moskvin, S. Combined laser therapy in cosmetology / SV Moskvin, L. Myslovich. – Tver: Triad, 2005. – 176. 613.4 M-822 Ab / *
27.Moskvin, S. The effectiveness of laser therapy / S. Moskvin. – M. : NPLTS “Technique”, 2003. – 67. 615.8 M-822 Ab / *
28.Nowakowski, A. A. Laser therapy in sports traumatology and orthopedics / A. A. Nowakowski. – Minsk Tehnoprint 2005. – 376 p. 616-001 H-723 Ab /
29.Peshev, h. P. Laser treatment in obstetric practice: monograph / h. P. Peshev, D. G. Dzhevebenava, A. R. Chkheidze. – Acad Mordovian Skog University Press, 1993. – 149 p. 618 P-318
30.Ponomarev, IV Copper vapor lasers in medicine and gold / IV Ponomarev. – M. : BI, 1998. – 68. 615.8 P-563 Ab / *
31.Prohonchukov, AA Lasers in Dentistry / AA Prohonchukov, NA Zhizhina. – M. : Medicine, 1986. – 176. 616.31 M-844 Ab /
32.Smetankin, IG Laser treatment of eye diseases. Techniques, indications, postoperative observation of patients / IG Smetankin, EV Pankstyanova, VA Murzin. – Nizhniy Novgorod: NGMA, 2000. – 56. 617.7 C-502 Ab / , c / o
33.Teals, VD lasers and their applications in biology and medicine: Textbook / VD Teals, NE Rubies, AN Liquors, D orkovsky Medical Institute. SM Kirov. – Bitter: GMI them. SM Kirov, 1978. – 64 p. 615.8 W-651 Ab / *
34.Shapovalov, SL Laser strobe ophthalmic diagnosis and treatment of pleoptic / SL Shapovalov, TI IBA, 35. AS Alexandrov. – Minsk: Military Clinical Hospital named. NNBurdenko, 2003. – 114. 617.7 W-241 Ab /
36.Aghajanova, KV Effect of low-intensity laser radiation on strukturoobrazovatelnye properties and biological effects of bacterial lipopolysaccharide: Author. dis. … Candidate. honey. Science : 14.03.03 / 37.KV Aghajanova. – Saratov: BI, 2010. – 24 p. A-38845 *
38. Alexandrova, O. Effect of intravenous laser irradiation of blood on endothelial function, microcirculatory disorders and some indicators of hemostasis in patients with essential hypertension: Author. dis. … Candidate. honey. Science : 14.00.05 / O. Alexandrov. – Vladikavkaz: BI, 2008. – 22. A-37027 *
39.Alekseev, A. Evaluating the effectiveness of the use of laser therapy in treatment of secondary pyelonephritis after contact lithotripsy (clinical and experimental study): Author. dis. … Candidate. honey. Science : 14.00.40 / AV Alexeev. – Saratov: BI, 2008. – 23 p. A-37029 *
40.Arsyutov, A. B. Pathophysiological rationale for the use of magnetic-laser therapy on the damaged tissue of the mucous membranes of the oral cavity: Author. dis. … Candidate. honey. Science : 14.00.16 / A. B. Arsyutov. – Saransk: BI, 2007. – 17. A-36380 *
41.Bergman, SW. Oe. Age-related changes in the lymph nodes are normal, with dentition defects and correction in laser and preparations (anatomical and experimental study): Author. dis. … Candidate. honey. Science : 14.03.01, 03.03.04 / S. Oe. Bergman. – Novosibirsk: BI, 2011. – 23 p. A-39619 *
42.Bovtunova, C. C. Reparative regeneration of muscle tissue rectal sphincter system under the action of laser radiation (experimental-morphological study): Author. dis. … Candidate. honey. Science : 03.03.04 / S. C. Bovtunova. – Orenburg: BI, 2011. – 30. A-40094 *
43.Budnik, And. A. Influence of low-intensity laser radiation on the adhesion and aggregation of platelets at different speed settings, the movement of blood and when the pH: Author. dis. … Candidate. honey. Science : 14.00.16 / S. A. Budnik. – Saratov: BI, 2007. – 25. A-36828 *
44.Vlasov, PG The use of yellow and mikroskleroterapii laser in the treatment of varicose veins of the 1st class and telangiectasia of the lower limbs: Author. dis. … Candidate. honey. Science : 14.00.27 / PG Vlasov. – Perm: BI, 2008. – 23 p. A-37383 *
45.Gazdanova, AA Effect of laser therapy on endothelial function and microcirculation some indicators of hemorheology in patients with stable angina: Author. dis. … Candidate. honey. Science : 14.00.05 / AA Gazdanova. – Vladikavkaz: BI, 2009. – 21. A-37947 *
46.Gadzatseva, ZM Improving the efficiency of complex treatment of chronic generalized periodontitis by the use of photodynamic laser system “HELBO”: Author. dis. … Candidate. honey. Science : 14.01.14 / ZM Gadzatseva. Stavropol -: BI, 2010. – 24 p. A-39311 *
47.Gottlieb, SA Treatment of acute and exacerbated chronic apical periodontitis using “Vagotila” and laser light: Author. dis. … Candidate. honey. Science : 14.00.21 / SA Gottlieb. – Tavropol: BI, 2009. – 21. A-37965 *
48.Grishilova, EN The use of fluorine-containing drugs and laser light to enhance the resistance of hard tissues of the prepared teeth: Author. dis. … Candidate. honey. Science : 14.01.14 / EN Grishilova. Stavropol -: BI, 2010. – 21 p. A-39302 *
49.Gutnova, C. C. Low-level laser therapy in the treatment of chronic pancreatitis: Author. dis. … Dr. med. Science : 14.01.04 / S. K. Gutnova. – Vladikavkaz: BI, 2011. – 40. A-40086 *
Dubrovin, A. A. Correction of hemodynamic disturbances in rosacea intense laser radiation: Author. dis. … Candidate. honey. Sciences: 14.01.10 / A. A. Dubrovin. – St. Petersburg. : BI, 2011. – 20. A-40182 *
50.Kehoeva, AU Effect of low-intensity laser radiation on endothelial function and microcirculation some indicators of hemorheology in patients with coronary heart disease associated with type 2 diabetes mellitus: Author. dis. … Candidate. honey. Science : 14.01.04 / A. Kehoeva. – Vladikavkaz: BI, 2010. – 22. A-39445 *
51.Kondyurova, Ye.. Comparative evaluation of the effectiveness of laser therapy and immunotherapy in the treatment of chronic periodontitis in patients with rheumatoid arthritis [electronic resource]: Author. dis. … Candidate. honey. Science : 14.00.21 / E. B. Kondyurova. – Electron. data (418 KB). – Nizhniy Novgorod: BI, 2008. FBS
52.Korolev, D. B. Combined use of ozone therapy and integrated magneto-infrared laser radiation in the treatment of patients with diabetic foot syndrome (experimental clinical research) [electronic resource]: Author. dis. … Candidate. honey. Science : 14.00.27 / A. B. Korolev. – Electron. data (385 KB). – Nizhniy Novgorod: BI, 2007. EBS
53.Krifaridi, AS Effect of low-intensity laser radiation on the cytokine system, the function of the vascular endothelium, some indicators of hemorheology and microcirculation in patients with chronic viral hepatitis: Author. dis. … Candidate. honey. Science : 14.00.05 / AS Krifaridi. – Vladikavkaz: BI, Aug. 20. – 22. A-37179 *
54.Lobanov, A.A.Obosnovanie combined use of neodymium and erbium lasers in the treatment of inflammatory periodontal diseases: Author. dis. … Candidate. honey. Science : 14.00.21 / AA Lobanov. – Samara: BI, 2008. – 21. A-37781 *
55.Losev, A. Effect of laser therapy on the clinical condition and the level of biologically active substances in the formed elements of the blood of patients with gastric ulcer and duodenal ulcer: Author. dis. … Candidate. honey. Science : 14.00.05 / AV Losev. – Kazan: BI, 2009. – 24 p. A-38557 *
56.Mammadov S. S. Intravascular laser irradiation of blood in the treatment of genital herpes in women of reproductive age: Author. dis. … Candidate. honey. Science : 14.00.01 / S. S. Mammadov. – M. : BI, 2007. – 24 p. A-36769 *
57.Makhan’kov, Oh. B. Combined effect of low-intensity laser radiation and bioactive peptides on the reparative process of skin lesions (experimental study): Author. dis. … Candidate. honey. Science : 14.00.16 / About. B. Makhan’kov. – Saratov: BI, 2007. – 22. A-36307 *
58.Musieva, HZ The influence of drug and magneto-infrared laser therapy on circadian blood pressure profile and the quality of life in patients with arterial hypertension: Author. dis. … Candidate. honey. Science : 14.00.06 / HZ Musieva. – Rostov-on-Don, BI, 2008. – 21. A-37434 *
59.Naibov, Oh. B. Clinical and experimental study on the use of diode laser in the treatment of destructive forms of apical periodontitis in adolescents: Author. dis. … Candidate. honey. Science : 14.00.21 / About. B. Naibov. – Yekaterinburg: BI, 2007. – 19. A-36388 *
60.Socks, NV. High-intensity laser radiation in treatment of aseptic necrosis of the femoral head of various etiologies in children (clinical and experimental work): Author. dis. … Candidate. honey. Science : 14.00.35 / NV Socks. – Ufa: BI, 2008. – 22. A-37231 *
61.Penzina, EB Neuro-immune disorders and their correction with low-intensity laser radiation in men with initial manifestations of insufficient blood supply to the brain: Author. dis. … Candidate. honey. Science : 14.00.13, 14.00.36 / EB Penzina. – Yekaterinburg: BI, 2008. – 29 p. A-37591 *
62.Pilieva, NG Effect of intravenous laser irradiation of blood microcirculation and some indicators of hemorheology in patients with community-acquired pneumonia: Author. dis. … Candidate. honey. Science : 14.00.05 / NG Pilieva. – Vladikavkaz: BI, 2008. – 21. A-37241 *
63.Radnaeva, D. C. Magneto-infrared laser therapy in treatment of traumatic lesions of the cornea (experimental clinical research): Author. dis. … Candidate. honey. Science : 14.00.08 / A. C. Radnaeva. – M. : BI, 2007. – 24 p. A-36088 *
64. Selivanov, On. Dr. Use of high-intensity laser radiation in the treatment of non-malignant skin pigmentation: Author. dis. … Candidate. honey. Science : 14.01.10 / O. D. Selivanov. – St. Petersburg. : BI, 2011. – 19. A-40062 *
65.Ushenina, LA Optimization of laser treatment of early stages of choroidal melanoma: Author. dis. … Candidate. honey. Science : 14.00.08 / LA Ushenina. – Chelyabinsk: BI, 2008. – 18. A-37636 *
66.Fedoruk, N. A. Morphological and histochemical features of subthreshold effects of laser radiation on the structure of the chorioretinal complex (experimental study): Author. dis. … Candidate. honey. Science : 14.01.07 / h. A. Fedoruk. – M. : BI, 2011. – 23 p. A-40219 *
67.Hlebina, Oh. B. Mechanisms of influence of infrared and helium-neon laser on detoxification, metabolic properties of blood, and regional hemodynamics in patients with inflammatory diseases of the uterus: Author. dis. … Candidate. honey. Science : 14.03.03, 14.01.01 / About. B. Hlebina. – Saratov: BI, 2010. – 22. A-39546 *
68.Shakhmaeva, A. B. Hypogalactia optimization of complex treatment using low-intensity laser radiation: Author. dis. … Candidate. honey. Science : 14.00.01 / A. B. Shakhmaeva. – Ufa: BI, 2007. – 22. A-36716 *
69.Shakhnazarova, ZA Intraportal laser therapy in the complex post-operative treatment of complicated cholecystitis: Author. dis. … Candidate. honey. Science : 14.00.27 / ZA Shakhnazarova. – Makhachkala: BI, 2009. – 19. A-38442 *
70.Shentsova, VV Comprehensive treatment of erysipelas using low-intensity laser radiation and ozone therapy: Author. dis. … Candidate. honey. Science : 14.00.10 / V. Shentsova. – Rostov-on-Don, BI, 2008. – 24 p. A-37374 *
71.Shtirshnayder, JJ Clinical and experimental justification for the use of diode laser with a wavelength of 0.81 microns in the treatment of patients with benign tumors of the skin: Author. dis. … Candidate. honey. Science : 14.01.10 / YY Shtirshnayder. – M. : BI, 2010. – 25. A-39079 *
72. Avdoshyn, VP Assessing the impact of radiation on the magneto for a pathological process in the kidneys of patients with renal colic in the experiment / VP Avdoshyn / / Urology. – 2007. – ? 4. – Pp. 20-25.
73.Adilhanova, NU The cytological picture of the effectiveness of laser therapy pathology limfoglotochnogo ring in children / NU Adilhanova / / Russian otolaryngology. – 2010. – ? 5. – P. 3-7.
74. Antoniuc, MV Integrated application of magnetic-laser therapy and polyunsaturated fatty acids in the treatment of patients with essential hypertension / MV Antoniuc / / Questions of the resorts, physiotherapy and medical physical culture. – 2011. – ? 1. – S. 9-13.
75. Baygaliev, AU Pulsed infrared laser radiation in the autorezonansnom mode in the treatment of patients with acute viral hepatitis B / A. Baygaliev / / Questions of the resorts, physiotherapy and medical physical culture. – 2010. – ? 6. – S. 24-25.
76. Belov, VV Evaluation of the factors effectiveness of low-intensity laser radiation in patients with unstable angina / VV. Belov / / Russian Journal of Cardiology. – 2008. – ? 4. – S. 16-19.
Burduli, NM Analysis of the effectiveness of various methods of laser therapy in the complex treatment of patients with gastric ulcer and duodenal ulcer / NM. Burduli / / Therapeutic Archives. – 2008. – T. 80, ? 2. – S. 30-33.
77.Burduli, NM Effect of low-intensity laser radiation on endothelial function and vascular system of cytokines in patients with chronic viral hepatitis / NM. Burduli / / Questions of the resorts, physiotherapy and medical physical culture. – 2011. – ? 2. – S. 30-34.
78. Burduli, NM Intravenous laser irradiation of blood endothelial dysfunction in hypertensive patients / NM. Burduli / / Clinical Medicine. – 2009. – T. 87, ? 6. – S. 22-25.
79. Burduli, NM The dynamics of plasma hemostasis parameters under the influence of intravascular laser irradiation of blood in patients with community-acquired pneumonia / NM. Burduli / / Therapeutic Archives. – 2010. – T. 82, ? 3. – S. 36-38.
80. Burduli, NM Types of microcirculation and laser therapy in chronic pancreatitis / NM. Burduli / / Clinical Medicine. – 2009. – T. 87, ? 8. – S. 56-61.
81. Verkhoglyad, IV Highly effective treatment of alopecia areata, using an excimer laser / IGOR. Verkhoglyad / / Experimental and Clinical dermatocosmetology. – 2009. – ? 1. – S. 41-44.
82. Verkhoglyad, IV Alopecia areata treatment using excimer laser, / IGOR. Verkhoglyad / / Russian Journal of Skin and Venereal Diseases. – 2009. – ? 3. – S. 69-70.
83.Verkhoglyad, IV Pathogenic aspects of alopecia areata and how to correct them using laser therapy. / IGOR. Verkhoglyad / / Attending physician. – 2009. – ? 5. – S. 22-24.
84.Vlasov. EJ Low-intensity laser therapy in the prophylactic treatment of children with giperergiey tuberculin / E.YU. Vlasov / / Tuberculosis and Lung Disease. – 2010. – ? 6. – S. 52-56.
85.Gatkin, EY The use of low-intensity laser radiation in treatment of children with dynamic ileus / EY 86.Gatkin / / Russian Journal of Perinatology and Pediatrics. – 2007. – T. 52, ? 2. – S. 57-61.
87.Gatkin, E. J. The effectiveness of laser photic stimulation in treatment of children with deep burns / EY Gatkin / / Doctor. – 2009. – ? 6. – S. 58-60.
88.Gatkin, EY The effectiveness of laser therapy in the treatment of children with neurogenic bladder dysfunction / EY Gatkin / / Russian Journal of Perinatology and Pediatrics. – 2009. – T. 54, ? 3. – S. 66-71.
89.Geynits, A.. Laser radiation in treatment of acute destructive pancreatitis / A. Geynits / / Surgery. – 2011. – ? 7. – S. 56-61.
90. Gizinger, OA Changing the dynamics of cytokines when exposed to low-intensity laser / OA. Gizinger / / Immunology. – 2009. – T. 30, ? 3. – S. 176-180.
91.Goydenko, VS Laser therapy and Mesodiencephalic modulation after hemihepatectomy in the early postoperative period / VS. Goydenko / / Problems of the resorts, physiotherapy and medical physical culture. – 2009. – ? 1. – S. 39-40.
92.Gulmuradova, NT Effect of low-intensity laser radiation on the immune status of acute pancreatitis / N.T. Gulmuradova / / Herald of intensive therapy. – 2011. – ? 3. – S. 33-35.
93.Huseynov, NM Diode laser removal of postoperative adhesions in the nasal cavity / NM. Huseynov / / Russian otolaryngology. – 2010. – ? 6. – S. 18-20.
94.Gutnova, SK Effect of low-level laser therapy on quality of life in patients with chronic pancreatitis / C. To. Gutnova / / Military Medical Journal. – 2010. – T. 331, ? 9. – S. 66-67.
95.Dolgushin II Effect of low-intensity laser radiation on neutrophils cervical secretions in women with mycoplasma infection / I.I. Dolgushin / / Questions of the resorts, physiotherapy and medical physical culture. – 2008. – ? 4. – S. 29-31.
96.Esaulenko, IE The use of laser puncture pain nym asthma soputsvuyuschim with chronic rhinosinusitis / IE Esaulenko / / Questions of the resorts, physiotherapy and medical physical training – 2009. – ? 1. – S. 37-39.
97.Zarkin, NA Combined magnetic-acupuncture in the prevention and treatment of imperative urinary incontinence in women after gynecological operations / NA. Zharkin / / Russian Journal of the obstetrician-gynecologist. – 2011. – T. 11, ? 2. – S. 54-60.
98.Zhuravlev, AS Intravenous laser irradiation of blood in complex treatment of patients with chronic sensorineural hearing loss / AS Zhuravlev / / Bulletin of otorhinolaryngology. – , 2011. – ? 2. – S. 43-45.
99.VD Zakharov Laser and surgical treatment of retinal vein thrombosis outcomes / VD Zakharov, OV Chestnut, IG Osokin / / Modern technologies in medicine.

Orthomolecular Medicine Scientific References:

1.”The method of determining proper doses of vitamin C for treatment of diseases by titrating to bowel tolerance.” Australian Nurses Journal 9(4):9-13 March, 1980. Also in: Journal of Orthomolecular Psychiatry 10:125-132, 1981. http://orthomolecular.org/library/jom/1981/pdf/1981-v10n02-p125.pdf

2.”Vitamin C, Titration to Bowel Tolerance, Anascorbemia, and Acute Induced Scurvy.” Medical Hypothesis 7:1359-1376, 1981. Also in Let’s Live (Japan) 16:9, Nov 1983. Also at http://www.doctoryourself.com/titration.html

3. “Vitamin C, the nontoxic, nonrate-limited antioxidant free radical scavenger.” Medical Hypothesis 18:61-77. 1985 .

4.”The vitamin C treatment of allergy and the normally unprimed state of antibodies.” Medical Hypothesis, 21(3):307-321 Nov 1986.

5.”A controversial protocol: Ascorbate challenges PCP.” The San Francisco Sentinel, Sept 12, 1986, page 9.

6.”A Unique Function for Ascorbate.” Medical Hypothesis 35:32-37 May 1991.

7.”The third face of vitamin C” J Orthomolecular Med, Vol 7, Number 4, p 197-200, 1992. Also at http://orthomolecular.org/library/jom/1992/toc4.shtml

8.Hickey DS, Roberts HJ, Cathcart RF. Dynamic flow: A new model for ascorbate. J Orthomolecular Med, Vol 20, Number 4, p 237-244, 2005. http://orthomolecular.org/library/jom/2005/pdf/2005-v20n04-p237.pdf

9.Dr. Free, P. Sanders “The Use of Ascorbic Acid and Mineral Supplements in the Detoxification of Narcotic Addicts.” Journal of Orthomolecular Psychiatry Vol 7, No. 4 264-270.

10.Dr. Libby, Dr. Stone. The H-K Approach to Drug Addiction Therapy. Journal of Orthomolecular Psychiatry Vol 6, No. 4 p 300—308.

11.Null G. “AIDS Scandal, new facts about prevention and treatment.” Penthouse, December 1985.

12.Lorch P. “The Ascorbate Doctor.” Bay Area Reporter XIV(10):6 March 8, 1984.

13.Coupland K. “The Vitamin C Resistance.” Sentinel USA, Part 1: January 17 1985, and part 2: January 31, 1985.

14.Lamble D. “Vitamin C. Debate continues.” Sentinel USA, 3//28/85.

15.Hoffer A & Osmond H. Paper to Dementia Praecox Committee, Scottish Rites Masons, New York. Given at the Canada Room, The Waldorf Astoria, New York, 1952. (“This was our first report on the adrenochrome hypothesis.”)

16.Hoffer A, Osmond H & Smythies J: Schizophrenia: a new approach. II. Results of a year’s research. J Ment Science 100:29-45, 1954.

17.Clancy J, Hoffer A, Lucy J, Osmond H, Smythies J & Stefaniak B: Design and planning in psychiatric research as illustrated by the Weyburn Chronic Nucleotide Project. Bull Men Clinic, 18:147-153, 1954.

18.Altschul R, Hoffer A & Stephen JD: Influence of nicotinic acid on serum cholesterol in man. Arch Biochem Biophys 54:558-559, 1955.

19.Szatmari A, Hoffer A & Schneider R: The effect of adrenochrome and niacin on the electroencephalogram of epileptics. Am J Psychiat 3:603-616, 1955.

20.Agnew N & Hoffer A. Nicotinic acid modified lysergic acid diethylamide psychosis. J Ment Science 101:12-27, 1955. (Abstract available Here)

21.Hoffer A. Effect of niacin and nicotinamide on leukocytes and some urinary constituents. Can Med Assoc J 74:448-451, 1955.

22.Hoffer A, Osmond H, Callbeck MJ & Kahan I: Treatment of schizophrenia with nicotinic acid and nicotinamide. J Clin Exper Psychopathol 18:131-158, 1957.

23.Hoffer A & Callbeck MJ: The hypocholesterolemic effect of nicotinic acid and its relationship to the autonomic nervous system. J Ment Science 103:810-820, 1957.

24.Hoffer A. The relationship of nicotinic acid to thyroid function. Can Med Assoc J 77:965 only, 1957.

25.Hoffer A. Adrenochrome and adrenolutin and their relationship to mental disease. Psychotropic Drugs. Eds. Garattini S & Ghetti V. Elsevier Press, London, 10-20, 1957.

26.Hoffer A. Adrenochrome and blood plasma. Amer J Psychiatry 114:752-753, 1958.

27.Hoffer A. Relation of epinephrine metabolites to schizophrenia. In: Chemical Concepts of Psychiatry. Eds: Rinkel M & Denber HGB. McDowell-Obolensky Inc., New York, 1958.

28.Altschul R & Hoffer A. Effects of salts of nicotinic acid on serum cholesterol. Brit Med J 2:713-714, 1958.

29.Altschul R & Hoffer A. The effect of nicotinic acid upon serum cholesterol and upon basal metabolic rate of young normal adults. Arch Biochem Biophysics 73:420- 424, 1958.

30.Hoffer A & Osmond H. The adrenochrome model and schizophrenia. J Nerv Mental Dis 128:18-35, 1959.

31.Osmond H & Hoffer A. Schizophrenia: A new approach III. J Ment Science 105:653-673, 1959.

32.Hoffer A & Callbeck MJ: Effect of nicotinic acid on liver function and leukocytes. Can Med Assoc J 80:736-737, 1959.

33.Hoffer A, O’Reilly PO & Callbeck MJ: Specificity of the hypocholesterolemic activity of nicotinic acid. Dis Nerv Syst 20:286-288, 1959.

34.Osmond H & Hoffer A. On critics and research. Psychosomatic Med 21:311-320, 1959.

35.Hoffer A. Treatment of arthritis by nicotinic acid and nicotinamide. Can Med Assoc J 81:235-238, 1959.

36.O’Reilly PO, Callbeck MJ & Hoffer A. Sustained-release nicotinic acid (Nicospan). Effect on (1) cholesterol levels and (2) leukocytes. Can Med Assoc J 80:359-362, 1959.

37.Hoffer A & Osmond H. The Chemical Basis of Clinical Psychiatry. C. C. Thomas, Springfield, IL, 1960.

38.Hoffer A & Osmond H. Alcoholism and the researcher. AA Grapevine 1960.

39.Altschul R & Hoffer A. Letter to Editor Re: Nicotinic acid on hypercholesterolemia. Can Med Assoc J 83:36-37, 1960.

40.Hoffer A & Osmond H. Concerning an etiological factor in alcoholism. The possible role of adrenochrome metabolism. Quart J Stud Alcohol 20:750-756, 1959.

41.Hoffer A. The adrenochrome hypothesis of schizophrenia. Paper read to Proc Sixth Ann Psychiatric Institute, Princeton, Sept 1958. Pub in Proceedings, 36-53.

42.Hoffer A. Adrenaline metabolites and schizophrenia. Dis Nerv Syst 21, Monograph Supp, 79-86, 1960.

43.Altschul R & Hoffer A. The effect of nicotinic acid on hypercholesterolemia. Can Med Assoc J 82:783-785, 1960.

44.Hoffer A. The relationship of nicotinic acid to cholesterol metabolism. J Clin Exper Psychopath 22: 165-179, 1961.

45.Hoffer A & Osmond H. The biochemistry of mental disease. Can Med Assoc J 85:1309-1311, 1961.

46.Hoffer A & Osmond H. Double blind clinical trials. J Neuropath 2:221-227, 1961.

47.Hoffer A. Ascorbic acid and schizophrenia. B.M.J. 1:1342 only, 1962.

48.Hoffer A. The effect of adrenochrome and adrenolutin on the behavior of animals and the psychology of man. Int Rev Neurobiology 4:307-371, 1962.

49.Hoffer A. Niacin Therapy in Psychiatry. C. C. Thomas, Springfield, IL, 1962.

50.Hoffer A & Osmond H. A card sorting test helpful in establishing prognosis. Am J Psychiatry 118:840-841,1962

51.Hoffer A & Osmond H. Some schizophrenic recoveries. Dis Nerv Syst 23:204-210, 1962

52.Hoffer A & Osmond H. Letter to Editor Re: Double blind clinical trials. J Neuropsychiatry 2:262-263, 1962.

53.Hoffer A & Osmond H. Letter to Editor: Adrenaline and schizophrenia. Lancet 1:643-644, 1962.

54.Hoffer A. Letter to Editor Re: Malnutrition and mental disease. Brit Med Assoc J 1:1342 only, 1962.

55.Hoffer A & Osmond H. Scurvy and schizophrenia. Dis Nerv Syst 24:273-285, 1963.

56.Hoffer A & Osmond H. A comprehensive theory of schizophrenia. Mind 1:119-121, 1963.

57.Hoffer A. What’s new in psychiatric research. Introduction. Mind. Psychiatry in General Practice, 1:28 only, 1963.

58.Osmond H & Hoffer A. Massive niacin treatment in schizophrenia. Review of a nine-year study. Lancet 1:316-320, 1963.

59.Smith CM, Hoffer A, Dantow MD & McIntyre S: Nicotinic acid in old age. The placebo effect and other factors in the collection of valid data. J Amer Geriat Soc 11:580-585, 1963.

60.Hoffer A. Nicotinic acid: an adjunct in the treatment of schizophrenia. Am J Psychiat 120:171-173, 1963.

61.Hoffer A. The adrenochrome theory of schizophrenia. a review. Dis Nerv Syst 25:173-178, 1964.

62.Hoffer A. Single case design and double blind comparison studies for drug evaluation. Mind. Psychiatry in General Practice, 2:119-120, 1964.

63.Hoffer A & Osmond H. Treatment of schizophrenia with nicotinic Acid – a ten year follow-up. Acta Psychiat Scand 40:171-189, 1964.

64.Hoffer A. Treatment of organic psychosis with nicotinic acid (a single case). Dis Nerv Syst 26: 358-360, 1965.

65.Hoffer A. Alcoholism Treatment and Research Center. The Can Forester, LXXXV, August 1965.

66.Hoffer A. Malvaria, schizophrenia and the HOD test. Int J Neuropsychiatry 2:175-177, 1965.

67.Osmond H & Hoffer A. A comprehensive theory of schizophrenia. Int J Neuropsychiatry 2:302-309, 1965.

68.Hoffer A. The effect of nicotinic acid on the frequency and duration of re-hospitalization of schizophrenic patients; A controlled comparison study. Int J Neuropsychiatry 2:234-240, 1966.

69.Hoffer A & Osmond H. How To Live With Schizophrenia. University Books, New York, NY, 1966. Also published by Johnson, London, 1966. Written by Fannie Kahan. New and Revised Ed. Citadel Press, New York, N.Y. 1992

70.Hoffer A. Use of nicotinic acid and/or nicotinamide in high doses to treat schizophrenia. Can J Psychiatric Nursing 76:5-6, 1966.

71.Hoffer A. Enzymology of Hallucinogens. In, Enzymes in Mental Health, J.B. Lippincott, 43-55, 1966.

72.Hoffer A & Osmond H. New Hope For Alcoholics, University Books, New York, 1966. Written by Fannie Kahan. Excerpt

73.Hoffer A. Biochemistry of nicotinic acid and nicotinamide. Psychosomatics 8:95-100, 1967.

74.Hoffer A & Osmond H. Nicotinamide adenine dinucleotide. J Psychopharm 1:79-95, 1967.

75.Kelm H, Hoffer A & Hall RW: Reliability of the Hoffer-Osmond Diagnostic test. J Clin Psychology 23:380-382, 1967.

76.Hoffer A. A theoretical examination of double-blind design. Can Med Assoc J 97:123-127, 1967.

77.Kelm H, Hoffer A & Osmond H. Hoffer-Osmond Diagnostic Manual. Saskatoon, 1967.

78.Hoffer A. Treatment of schizophrenia with a therapeutic program based upon nicotinic acid as the main variable. Molecular Basis of Some Aspects of Mental Activity, Vol II. Ed. O Walaas, Academic Press, New York, 1967.

79.Kelm H, Callbeck MJ & Hoffer A. A short form of the Hoffer-Osmond Diagnostic test. Int J Neuropsychiatry 3:489-490, 1967.

80.Hoffer A. Nicotinamide adenine dinucleotide in the treatment of chronic schizophrenic patients. British J Psychiatry 114:915-917, 1968.

81.Hoffer A & MacLean JR: A brief history of the American Schizophrenia Foundation. Schizophrenia 1:10-12, 1969.

82.Hoffer A. Comparison of xanthine nicotinate and nicotinic acid as treatment for schizophrenia. Schizophrenia 1:24- 37, 1969.

83.Hoffer A. Safety, side effects and relative lack of toxicity of nicotinic acid and nicotinamide. Schizophrenia 1:78-87, 1969.

84.Hoffer A. Adverse effects of niacin in emergent psychosis. J Am Med Ass 207:1355 only, 1969. (Available here)

85.Hoffer A. Introduction to Mental Health Through Nutrition, by Judge Tom R. Blaine, The Citadel Press, New York, 1969.

86.Hoffer A. Pellagra and schizophrenia. Academy of Psychosomatic Medicine, Buenos Aires, Jan. 12-18, 1970. Psychosomatic II, 522-525, 1970.

87.Hoffer A. Living with schizophrenia: An Unusual Case of Schizophrenia in a Man of 56. Schizophrenia 2:80-86, 1970.

88.Hoffer A. Childhood schizophrenia. a case treated with nicotinic acid and nicotinamide. Schizophrenia 2:43-53,1970.

89.Hoffer A & Osmond H. Vitamin B-3 and Krebiozen – a polemic. Schizophrenia 2:161-165, 1970.

90.Hoffer A. Symposium on statistical aspects of protocol design. Discussion. Cancer Clinical Investigation Review Committee, San Juan, Puerto Rico, 224-229, Dec. 9-10, 1970.

91.Hoffer A. A vitamin B-3 dependent family. Schizophrenia 3:41-46, 1971.

92.Hoffer A. Megavitamins Can Psychiatric Ass J. 19:124-5, 1971

93.Hoffer A. Letter to Editor. Ascorbic acid and schizophrenia. C.M.C. News 2, May 1971.

94.Hoffer A. Letter to Editor. (Rebuttal of attack on Linus Pauling) Nutrition Today 6:34-35, 1971.

95.Hoffer A. Vitamin B-3 dependent child. Schizophrenia 3:107-113, 1971.

96.Hoffer A. Ascorbic acid and toxicity. New England J of Med 285:635-636, 1971.

97.Hoffer A. Vitamin C and the common cold. Can Med Assoc J 105:901-902, 1971.

98.Hoffer A. Megavitamin B-3 therapy for schizophrenia. Can Psychiatric Ass J 16:499-504, 1971.

99.Masters AB, Hoffer A, Nair NPV, Messer CJ, Zarzadias R & Moraes C: Care of chronic psychotics. Brit Med Ass J 4:489 only, 1971.

100.Hoffer A. Foreword to, Body Mind and the B Vitamins by R Adams & F Murray. Larchmont Books, New York, 1972.

101.Hoffer A. LSD-induced psychosis and vitamin B-3. Amer J Psychiatry 128:145 only, 1972

102.Hoffer A. Orthomolecular treatment of schizophrenia. Orthomolecular Psychiatry 1:46-55, 1972.

103.Hoffer A. Treatment of hyperkinetic children with nicotinamide and pyridoxine. Can Med Assoc J 107:111-112, 1972.

104.Hoffer A. Orthomolecular treatment for schizophrenia. J Practical Nursing 22:16-19 and 20-22, 1972.

105.Hoffer A. LSD-induced psychosis and vitamin B-3 Amer J of Psychiatry. 128; 1155 only, 1972

106.Hoffer A. Senility is a form of chronic malnutrition. Report of a National Conference on The Crisis in Health Care For The Aging, sponsored by the Huxley Institute of Biosocial Research, New York, Mar. 6, 1972.

107.Hoffer A. Clofibrate and nicotinic acid. Can Med Assoc J 107:488-489, 1972.

108.Hoffer A. Orthomolecular treatment for schizophrenia. Medical Counterpart 4:10-20, 1973.

109.Hoffer A. Mechanism of action of nicotinic acid and nicotinamide in the treatment of schizophrenia. In, Orthomolecular Psychiatry, Eds. David Hawkins and Linus Pauling. WH Freeman and Co., San Francisco, 1973.

110. Hoffer A. Schizophrenia: An Evolutionary Advance. J Orthomolecular Psychiatry 2:39, 1973.

111.Hoffer A. Orthomolecular therapy. Psychiatric Opinion 10:6-10, 1973.

112.Hoffer A. An examination of the double-blind method as it has been applied to megavitamin therapy. Orthomolecular Psychiatry 2:107-114, 1973.

113.Hoffer A. Orthomolecular treatment of schizophrenia. Can J Psychiat Nursing 14:11-14, 1973.

114.Hoffer A. Adverse effects of niacin in emergent psychosis. J.A.M.A. 207:1355 only, 1973.

115.Hoffer A. Learning disability. Can Med Assoc J 109:574 only, 1973.

116.Hoffer A. Vitamin C and infertility. The Lancet 2:1146 only, 1973.

117.Hoffer A. The great vitamin spree – pro and con. BC Med J 15:350 only, 1973.

118.Hoffer A. Orthomolecular psychiatry. BC Med J 16:137-140, 1974.

119.Hoffer A. Hallucinogens. Encyclopedia Britannica 15th Ed., 557-560, 1974.

120.Hoffer A. Double blind studies. Can Med Assoc J 111:752 only, 1974.

121.Hoffer A. Treatment of choice. Saint Johns Edmonton Report, Volume 1, 1974.

122.Hoffer A. The megavitamin scene. The Lancet 2:908 only, 1974.

123.Hoffer A. Hyperactivity, allergy and megavitamins. Can Med Assoc J 111:905-907, 1974.

124.Hoffer A. Senility and chronic malnutrition. J Orthomolecular Psychiatry 3:2-19, 1974.

125.Hoffer A. The orthomolecular controversy. J Orthomolecular Psychiatry 3:164-166, 1974.

126.Hoffer A. History of orthomolecular psychiatry. J Orthomolecular Psychiatry 3:223-230, 1974.

127.Hoffer A. The drug addictions. The Answer 11:2-5 & 38-40, 1974.

128.Hoffer A. Calories, protein, lipids, carbohydrates and the Saccharine Disease. J Orthomolecular Psychiatry 3:231-239, 1974.

129.Hoffer A. Treatment of schizophrenia. J Orthomolecular Psychiatry 3:280-290, 1974.

130.Hoffer A. The relation of crime to nutrition. Humanist in Canada 34:2-9, 1975.

131.Hoffer A. Nutrition and schizophrenia. Canadian Family Physician 21:78-82, 1975.

132. Hoffer A. Nutrition and Schizophrenia; the debate continues. Canadian Family Physician 21:15-16, 1975.

133. Hoffer A. A note on folklore and medical discovery. J Orthomolecular Psychiatry 4:211 only, 1975.

134.Hoffer A. Orthomolecular Medicine: What is it, How does it work. Impact of Science on Society 25:233-244, 1975.

135.Hoffer A, Kelm H & Osmond H. The Hoffer-Osmond Diagnostic Test. RE Krieger Pub Co. Huntington, New York, 1975.

136.Hoffer A. The orthomolecular controversy. J Orthomolecular Psychiatry 5:54-67, 1976.

137.Hoffer A. Editorial. Establishment journal looks at orthomolecular psychiatry. J Orthomolecular Psychiatry 5:78-83, 1976.

138.Hoffer A. Natural history and treatment of thirteen pairs of identical twins, schizophrenic and schizophrenic-spectrum conditions. J Orthomolecular Psychiatry 5:101-122, 1976.

139.Hoffer A & Osmond H. Megavitamin Therapy. Can Schiz Foundation, Regina, 1976.

140.Stone I & Hoffer A. The genesis of medical myths

. J Orthomolecular Psychiatry 5:163-168, 1976.

141.Hoffer A. Megavitamin therapy for different cases. J Orthomolecular Psychiatry 5:169-182, 1976.

142.Hoffer A. Children with learning and behavioral disorders. J Orthomolecular Psychiatry 5:228-230, 1976.

143.Hoffer A & Osmond H. In Reply to The American Psychiatric Association Task Force Report on Megavitamin and Orthomolecular Therapy in Psychiatry. Canadian Schizophrenia Foundation, Regina, Sask., now 16 Florence Ave., Toronto, ON, Canada M2N 1E9, August 1976. Full text posted at

144.Hoffer A. The double blind method. Can Psych Ass Journal 6:449-450, 1976.

145.Hoffer A. Editorial. The Medical Model and Mileau Therapy. J Orthomolecular Psychiatry 5:246-252, 1976.

146.Hoffer A. Editorials. Does ascorbic acid destroy vitamin B-12? and Crime: the price of chemical tranquility. J Orthomolecular Psychiatry 6:2-7, 1977.

147.Hoffer A. Orthomolecular psychiatry in theory and practice. Drug Therapy 79-85, 1977.

148.Hoffer A. On evidence. Canadian Doctor 43:30 only, 1977.

149.Hoffer A. Evidence and belief. Can Med Assoc J 117:733-734, 1977.

150.Hoffer A. To the Editor. Tardive dyskinesia treated with manganese. Can Med Assoc J 117:859 only, 1977.

151.Hoffer A. An Interview. Ex-POW Bull Volume 34, Sept 30-33 and Oct 19-23, 1977.

152.Hoffer A. Editorial. Rules of inquiry. About the APA Task Force on Megavitamin Therapy and Orthomolecular Psychiatry. J Orthomolecular Psychiatry 7:82-85, 1978.

153.Hoffer A. Diagnosing depression. J Orthomolecular Psychiatry 7:177-179, 1978.

154.Hoffer A & Walker M: Orthomolecular Nutrition. Keats Pub, New Canaan, CT, 1978.

155.Hoffer A. Some theoretical principles basic to orthomolecular psychiatric treatment. In: Ecologic-Biochemical Approaches to Treatment of Delinquents and Criminals. Ed. LJ Hippchen. Van Nostrand-Reinhold Co, New York, 31-55, 1978.

156.Hoffer A. Letter to Editor. Megavitamins versus tranquilizer therapy. Canadian Family Physician 24:410 only, 1978.

157.Hoffer A. and Osmond H. Color in our Pills, J Orthomolecular Medicine 8:2, 1979.

158.Hoffer A. Orthomolecular psychiatry. Proc Section World Congress Biol Psychiatry, Barcelona, 1978. Elsevier North Holland Biomedical Press BV Amsterdam 1979.

159.Hoffer A. Obsessions and depression. J Orthomolecular Psychiatry 8:78-81, 1979.

160.Hoffer A. Behavioral nutrition. J Orthomolecular Psychiatry 8:169-175, 1979.

161.Hoffer A. Crime, punishment and treatment. J Orthomolecular Psychiatry 8:193-199, 1979.

162.Hoffer A & Walker M: Nutrients to Age Without Senility. Keats Pub Inc, New Canaan, CT, 1980

163.Hoffer A. Newer trends in orthomolecular medicine. Newsletter, Northwest Academy Preventive Med 7 pages 3 and 6, 1980.

164.Hoffer A & Osmond H. Schizophrenia. another long term follow-up in Canada. J Orthomolecular Psychiatry 9:107-113, 1980.

165.Hoffer A. To the Editor. Crime and delinquency. A reply to H Wagemaker, Biol Psychiatry 15:171-172, 1980. Biological Psychiatry 26:249-250, 1980.

166.Hoffer A. Mega amino acid therapy. J Orthomolecular Psychiatry 9:2-5, 1980.

167.Hoffer A. Allergy, depression and tricyclic anti-depressants. J Orthomolecular Psychiatry 9:164-170, 1980.

168.Hoffer A. Megavitamins Biol Psychiatry 15:821-2, 1980

169.Hoffer A. Letter to the Editor, re critique of Leonard Hippchen’s book, Ecologic-Biochemical Approaches to Treatment of Delinquents and Criminals, by T. J. Gaensbauer. Crime and Delinquency 26:249-250, 1980.

170.Osmond H & Hoffer A. Naturally occurring endogenous major and minor tranquilizers. J Orthomolecular Psychiatry 9:198-206, 1980.

171.Hoffer A. Megavitamin Therapy. In: The Psychotherapy Handbook. 370-374, Ed.R Herink. New American Library, New York, 1980.

172.Hoffer A. The Adrenochrome Hypothesis of Schizophrenia Revisited. J Orthomolecular Psychiatry 10:98-118, 1981.

173.Hoffer A. Editorial. Mercury-Silver Amalgams. J Orthomolecular Psychiatry 11:2 only, 1982.

174.Hoffer A. Why nicotinic acid lowers lipid levels. Can Med Assoc J 128:372 only, 1983.

175.Hoffer A. Nutrition and cancer. Anabolism, J Preventive Med 2:5-7, 1983. Ed. R Powell, La Jolla, CA.

176.Hoffer A. Nutrition and behavior. In, Medical Applications of Clinical Nutrition. Ed. J Bland. Keats Pub, New Canaan CT, 222-251, 1983.

177.Hoffer A. Latent Huntington’s disease – response to orthomolecular treatment. J Orthomolecular Psychiatry 12:44-47, 1983.

178.Hoffer A. Update: (a) treatment of multiple sclerosis with hyperbaric oxygen. (b) Niacin hepatitis. J Orthomolecular Psychiatry 12:89-90, 1983.

179.Hoffer A. Orthomolecular nutrition at the zoo. J Orthomolecular Psychiatry 12:116-128, 1983.

180.Hoffer A. Editorial. Criticism. J Orthomolecular Psychiatry 12:252-259, 1983.

181.Hoffer A. Oxidation-reduction in the brain. J Orthomolecular Psychiatry 12:292-301, 1983.

182.Hoffer A. Comments on prevention. Canada’s Mental Health 32:23 only, 1984.

183.Hoffer A. Megavitamin therapy. Times Colonist, Victoria, BC, March 29, 1984.

184.Hoffer A. Nutritional ignorance. B.C. Med J 26:345 only, 1984.

185.Hoffer A. Letter to Editor. Health Food Retailing, Australia, September 1984, page 25 only.

186.Hoffer A. Orthomolecular treatment of schizophrenia. Society for Environmental Therapy 4:3-6, 1984.

187.Hoffer A. Treating schizophrenia. Australasian Health and Healing 4:7-14, 1984.

188.Hoffer A. Gastric bypass surgery and nutrient deficiency. Can Med Assoc J 131:1019 only, 1984

189.Hoffer A. Editorial. The Controversial Vitamins. J Orthomolecular Psychiatry 13:2-5, 1984.

190.Hoffer A. Vitamin B-3 (Niacin). Keats Pub, New Canaan CT, 1984.

191.Hoffer A. Editorial. The tomato effect. J Orthomolecular Psychiatry 13:142-143, 1984.

192.Hoffer A. Editorial. On pain, developmental defects, and vitamin safety. J Orthomolecular Psychiatry 14:2-4, 1985.

193.Hoffer A. Foreword to Living With Schizophrenia. J Orthomolecular Psychiatry 14:39-41, 1985.

194.Hoffer A. Editorial. A basic flaw in modern medical research. J Orthomolecular Psychiatry 14:82-84, 1985.

195.Hoffer A. Thyroid and cancer. J Orthomolecular Psychiatry 14:85-87, 1985.

196.Hoffer A. Huntington’s disease: a follow-up. J Orthomolecular Psychiatry 13:42-44, 1984.

197.Hoffer A. Letter to Editor. Nutrition Today, About Niacin 20:36 only, 1985.

198.Hoffer A. Dopamine, noradrenalin and adrenalin metabolism to methylated or chrome indole derivatives: two pathways or one? J Orthomolecular Psychiatry 14:262-272, 1985.

199.Hoffer A. Ascorbic acid and kidney stones. Can Med Assoc J 132:320 only, 1985.

200.Hoffer A. Children’s Multiple Vitamin overuse lead to overdose CMAJ 133:13 only, 1985

201.Hoffer A. Vitamin B-3. Can Med Assoc J 135:1250 only, 1986.

202.Hoffer A. Vitamin Therapy For Hyperactivity and Schizophrenia. a family’s struggle. J Orthomolecular Medicine 1:57-62, 1986.

203.Hoffer A. Editorial. The New Debate in Nutrition. J Orthomolecular Medicine 1:72 only, 1986.

204.Hoffer A. Editorial. Nutrition in Institutions Controlled by Physicians. J Orthomolecular Medicine 1:216-218, 1986.

205Hoffer A. Editorial. Seminar on Orthomolecular Medicine. Ben Gurion University Medical Center, May 21, 1987. J Orthomolecular Medicine 2:2 only, 1987.

206.Hoffer A. Editorial. Why Flog a Dead Horse? J Orthomolecular Medicine 2:74 only, 1987.

207.Hoffer A. Editorials: ‘Schizophrenia and Suicide’ and ‘Let’s Help the FDA’. J Orthomolecular Medicine 2:144-145, 1987.

208.Hoffer A. Is There a Conspiracy? J Orthomolecular Medicine 2:158-165, 1987.

209.Hoffer A. Vitamin B-3 CMAJ 137:12 only, 1987

210.Hoffer A. Linus Pauling Honors the Canadian Schizophrenia Foundation. J Orthomolecular Medicine 2:183-184, 1987.

211.Hoffer A. How to Study a Controversial Area in Medicine. J Orthomolecular Medicine 3:207-210, 1987.

212.Hoffer A. Further Report on a Schizophrenic Patient who had Hyperasparaginemia J Orthomolecular Medicine 2:213-216, 1987.

213.Hoffer A. Editorial. Winds of Change. J Orthomolecular Medicine 2:221-222, 1987. Editorial.

214.Hoffer A. Control of Huntington’s Disease by Orthomolecular Treatment. J Orthomolecular Medicine 2:229 only, 1987.

215.Hoffer A. Editorial. How Can Anything So Simple Help Something So Complicated? J Orthomolecular Medicine 3:2 only, 1988.

216.Hoffer A. Letter to Editor. Fluoridation: why is it not more widely adopted? Can Med Assoc J 138:11 only, 1988.

217.Hoffer A. Common Questions on Schizophrenia and Their Answers. Keats Pub, New Canaan, CT, 1988.

218.Hoffer A. Can alternative and conventional treatments of cancer co-exist? Health Sciences Program, University Extension and Community Relations, University of Victoria, Feb 8, 1989.

219.Hoffer A. In Memoriam: Carl C. Pfeiffer, B.A., Ph.D., M.D. 1908-1988 and Here. J Orthomolecular Medicine 4:3-5, 1989.

220.Hoffer A. The Discovery of Vitamin C: Albert Szent-Gyorgi, M.D. Ph.D. 1893-1986. J Orthomolecular Medicine 4:24-26, 1989.

221.Hoffer A. Editorial. This is What They Said about Medical Mavericks. J Orthomolecular Medicine 4:54-57, 1989.

222.Hoffer A. The Bristol Regimen for Cancer Treatment CMAJ 144:411-412, 1989

223.Hoffer A. The Fluoride Controversy – The First Forty Years. J Orthomolecular Medicine 4:119-122, 1989.

224.Hoffer A. Preface. In The Best of Health. The 101 Best Books. Sheldon Zerden, Four Walls Eight Windows, New York, xi- xii, 1989

225.Hoffer A. Editorial. An Historical Note. J Orthomolecular Medicine 4:183-184, 1989.

226.Hoffer A. Niacin, Coronary Disease and Longevity. J Orthomolecular Medicine 4:211-220, 1989.

227.Hoffer A. Letter to Editor. Dr. Reading under fire in Australia. J Orthomolecular Medicine 4:234-235, 1989.

228.Hoffer A. Vitamin and mineral supplements increase intelligence. Nutrition Health Review, Fall 1989

229.Hoffer, A. Editorial. Psychiatry J Orthomolecular Medicine 2:59, 1990

230.Hoffer A. Editorial. Adrenochrome Hypothesis Revisited. J Orthomolecular Medicine 5:3 only, 1990.

231.Hoffer A & Osmond H. The Adrenochrome Hypothesis and Psychiatry. J Orthomolecular Medicine 5:32-45, 1990.

232.Hoffer A. Cancer and Vitamin C. J Orthomolecular Medicine 5:123 only, 1990.

233.Hoffer A, Walker, M: Senility is not inevitable – history proves otherwise – notable historic figures accomplished great things at advanced ages. Nutrition Health Review, Winter 1990

234.Hoffer A & Pauling L. Hardin Jones biostatistical analysis of mortality data for cohorts of cancer patients with a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients receiving large regular oral doses of vitamin C and other nutrients with similar patients not receiving those doses. J Orthomolecular Medicine 5:143-154, 1990. Reprinted in, Cancer and Vitamin C, E Cameron and L Pauling, Camino Books, Inc. P.O. Box 59026, Phil. PA, 19102, 1993.

235.Hoffer A. & Pauling L. Oral Citrus Seed Extract in Atopic Eczema: In Vitro and In Vivo Studies on Intestinal Microflora. J Orthomolecular Medicine 5:155, 1990.

236.Hoffer A. Editorial. More on fluoride, on mercury and teeth, and on Alaska Bill #146. J Orthomolecular Medicine 5:187-188, 1990.

237.Hoffer A. The prevention of tardive dyskinesia (tranquilizer induced illness). Open Forum for Health Information of New Zealand, Aug-Sept 1990, 17-20.

238.Hoffer A. Vitamin B-3 (Niacin) Update. New Roles For a Key Nutrient in Diabetes, Cancer, Heart Disease and Other Major Health Problems. Keats Pubs., Inc., New Canaan, CT, 1990.

239.Hoffer A. Letter to editor. Megavitamin and megamineral therapy in childhood. Reply to Appeltauer LC. Can Med Assoc J 145:105 only, 1991.

240.Hoffer A. Megavitamin and megamineral therapy in childhood. Can Med Assoc J 144:845-846, 1991.

241.Hoffer A. Editorials. Linus Pauling’s 90th birthday. (and) National Cancer Institute and vitamin C. (and) In Memoriam: William Beebe, M.D. J Orthomolecular Medicine 6:3-4, 1991.

241.Hoffer A. Megavitamin and megamineral therapy in childhood. Can Med Assoc J, 144:845-846, 1991.

242.Hoffer A. Does decreasing cholesterol levels increase the death rate from accidents, homicides and suicide? J Orthomolecular Medicine 6:44-45, 1991.

243.Hoffer A. Editorial. Freedom of Choice Wins More Freedom. J Orthomolecular Medicine 6:55-56, 1991.

244.Hoffer A. Report of the Pharmaceutical Inquiry of Ontario on Alternative Therapies. J Orthomolecular Medicine 6:104-109, 1991.

245.Hoffer A. Orthomolecular Medicine. In: Molecules In Natural Science and Medicine, An Encomium for Linus Pauling. Ed ZB Maksic & M Eckert-Maksic, Ellis Horwood Ltd, Chichester, West Sussex, England, 1991.

246.Hoffer A. Double standard in the control of drugs and nutrients. Healthy Options, 11-13, April/May, New Zealand, 1991.

247.Hoffer A. Niacin Reaction. J of Family Practice, 34: 677 only, 1992.

248.Hoffer A. Protection against ultraviolet radiation. Can Med Ass J, 147:839-840, 1992

249.Hoffer A. Re: Antioxidant vitamins. British Columbia Medical Association Journal, 35:148 only, 1993.

250.Hoffer A. Isoniazid and pyridoxine. Can Med Assoc J, 149:1232 only, 1993.

251.Hoffer A & Pauling L: Hardin Jones Biostatistical Analysis of Mortality Data for Cohorts of Cancer Patients with a Large Fraction Surviving at the Termination of the Study and a Comparison of Survival Times of Cancer Patients Receiving Large Regular Oral Doses of Vitamin C and Other Nutrients with Similar Patients not Receiving those Doses. J Orthomolecular Medicine 5:143-154, 1990. Reprinted in Cancer and Vitamin C, E. Cameron and L. Pauling, Camino Books, Inc. P.O. Box 59026, Phil. PA 19102, 1993.

252.Hoffer A. The True Cost of Cynicism. Why Vitamin E was Ignored as Heart Therapy for 40 Years. Journal of Orthomolecular Medicine Vol. 7, No. 4, 1992

253.Hoffer A. Editorial: The Politics of Medical Research; Alternative Medicine Liberated in a Second State. J of Orthomolecular Medicine, 8:3-5, 1993.

254.Hoffer A. A case of Alzheimer’s treated with nutrients and aspirin. J of Orthomolecular Medicine 8:43-44, 1993.

255.Letter. Hoffer A. Bill W. Cofounder of Alcoholics Anonymous and Vitamin B-3. J of Orthomolecular Medicine 8:57-58, 1993.

256.Hoffer A. Misconduct in High Places; Freedom to Practice Complementary Medicine Gaining Momentum. J of Orthomolecular Medicine, 8:67-68, 1993.

257.Hoffer A. Orthomolecular medicine advances into the mainstream. J of Orthomolecular Medicine, 8:99-103, 1993.

258.Hoffer A. Editorial Lysine, Ascorbic Acid and Angina Pectoris; The Discovery of Heparin. J of Orthomolecular Medicine, 8:131, 1993.

259.Hoffer A & Pauling L: Hardin Jones biostatistical analysis of mortality data for a second set of cohorts of cancer patients with a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients receiving large regular oral doses of vitamin C and other nutrients with similar patients not receiving these doses. J of Orthomolecular Medicine, 8:157-167, 1993.

260.Hoffer A. Orthomolecular Oncology. In, Adjuvant Nutrition in Cancer Treatment, Ed. P Quillin & RM Williams. 1992 Symposium Proceedings, Sponsored by Cancer Treatment Research Foundation and American College of Nutrition. Cancer Treatment Research Foundation, 3455 Salt Creek Lane, Suite 200, Arlington Heights, IL 60005-1090, 331-362, 1994.

261.Hoffer A & Walker M: Smart Nutrients – A Guide to Nutrients That Can Prevent and Reverse Senility. Avery Publishing Group, Garden City Park, NY, 1994.

262.Hoffer A. Nutritional Relief for Schizophrenia. Health Naturally, 28-29, Dec 1993/Jan 1994.

263.Hoffer A. The Megavitamin Revolution. Health Counselor, 5:8-9, 1994.

264.Hoffer A. Chronic schizophrenic patients treated ten years or more. J. Orthomolecular Medicine, 9:7-37, 1994.

265.Hoffer A. Orthomolecular Oncology and Survival. 2nd International Symposium, Adjuvant Nutrition in Cancer Treatment, San Diego, Mar 17-19, 1994.

266.Hoffer A. Vitamin B-3 and Schizophrenia. Discovery, Recovery, Controversy. Quarry Press, Kingston, ON, 1995.

267.Hoffer A : Vitamin C and Cancer: Discovery, Recovery, Controversy. Quarry Press, Kingston, ON, 1995. Review

268.Hoffer A: The Discovery of Kryptopyrrole and its Importance in Diagnosis of Biochemical Imbalances in Schizophrenia and in Criminal Behavior. Journal of Orthomolecular Medicine, Volume 10, First Quarter, 1995, p 3.

269.Hoffer A. A dedication to Linus Pauling. The Health Guardian. Health Guard Distributing Corporation, Burnaby, BC, 1:2 only, 1995. .

270.Hoffer A. Nutrition Therapy for Cancer Patients. 3rd International Symposium, Adjuvant Nutrition in Cancer Treatment. Tampa, Florida, Sept 28-30, 1995 .

271.Hoffer A. Editorial: Double blind studies often the bane of health advancement; (and) Report on disciplinary proceeding: the State of New York against Warren Levin, M.D. J of Orthomolecular Medicine, 9:195-198, 1994.

272.Hoffer A. Another anecdote of schizophrenia. Psychological activity of nicotinamide adenine dinucleotide (NAD) J. Orthomolecular Medicine 10:68-69, 1995.

273.Hoffer A. Vitamin B-3: Niacin and its amide. Townsend Letter for Doctors and Patients No. 147, Oct 1995, 30-39.

274.Hoffer A. Orthomolecular Treatment of Cancer. In, Nutrients in Cancer Prevention and Treatment. Ed. Prasad KN, Santamaria L & Williams RM. Pages 373-391, 1995, Humana Press, Totowa, New Jersey.

275.Hoffer A. Treatment of Schizophrenia. Townsend Letter for Doctors and Patients No. 144, July 1995, 52-57. .

276.Hoffer A: Editorial – The Megavitamin Revolution. Journal Of Orthomolecular Medicine Vol. 7, No. 1, 1995

277.Hoffer A. Schizophrenia. An Evolutionary Defense Against Severe Stress. Townsend Letter for Doctors and Patients No. 151/152, Feb/March 1996.

278.Hoffer A. Inside Schizophrenia: Before and After Treatment, J Orthomolecular Medicine 11:45, 1996

279.Hoffer A. Hoffer’s Law of Natural Nutrition. Quarry Press, Kingston, ON, 1996.

280.Hoffer A. The Vitamin Paradigm Wars. Townsend Letter for Doctors and Patients No. 155, 56-60, 1996.

281.Hoffer A. Using Vitamins and Nutrition to Help Schizophrenics. An Orthomolecular Alternative. Schizophrenia Digest, 3:13-15, 1996.

282.Hoffer A. Epidermolysis Bullosa. A Zinc Dependent Condition? Townsend Letter for Doctors and Patients No.161, Dec 1996, 62-63.

283.Hoffer A; One Patient’s Recovery from Lymphoma Townsend Letter for Doctors and Patients No.160, 50-51, 1996.

284.Hoffer A. Interview by Dr. J. Wright. In Let’s Live 64, 31-33, 1996.

285.Hoffer A. Schizophrenia. Interviewed by Linda Lazarides, Nutritional Therapy Today 6:6-8, 1996, with an addendum in a letter.

286.Hoffer A. How To Live Longer and Feel Better – Even With Cancer. Journal of Orthomolecular Medicine 11:147-167, 1996.

287.Hoffer A. Editorial: The Future of Psychiatry. Vol. 11, No. 1, 1996

288.Hoffer A. Huntington’s Disease. Townsend Letter for Doctors and Patients No.163/164, 46-51, 1997.

289.Hoffer A. Arthritis. Townsend Letter for Doctors and Patients. December, No. 173 104 to 106, 1997

290.Hoffer A. Lupus Erythematosis. Townsend Letter for Doctors and Patients, No. 171, 74 to 75, 1997. Reprinted same journal No. 93/194, page 22-23, 1999

291.Hoffer A. An anecdote describing the treatment of one case of schizophrenia. No. 168, page 76-79, 1997

292.Hoffer A. Interview by Peter Barry Chowka On Orthomolecular Medicine, 1997

293.Cover Story Amer J Natural Med June Gaining Control of Schizophrenia 5:21-25, 1998

294.Hoffer A. Editorial July/August (1998?) Amer J Natural Med. Treatment of Children with Learning and/or Behavioral Disorders

295.Hoffer A. The niacin story: The first orthomolecular compound Amer J Natural Med, 5, 10-3, 1998

296.Hoffer A. Treating Children with Learning and/or Behavior Disorders. Amer J of Natural Med Editorial 5; 7-9, 1998

297.Hoffer A. Orthomolecular Psychiatry. The Whole Mind, Ed L. Bassman, New World Library, 14 Pamaron Way. Novato, Cal. 94949, Pages 423-432, 1998

298.Hoffer A. Stress Busters. Great Life 1; 28-31, 1998

299.Hoffer A. Orthomolecular Treatment of Schizophrenia. Complementary Medicine. Official Journal of the South African Complementary Medicine Association. 4, 9-14, 1998

300.Hoffer A. Unproven cancer therapies 31, 160 only, 1998

301.Hoffer A. Orthomolecular Psychiatry in Theory and Practice. Townsend Letter for Doctors and Patients No. 174, 107-111, 1998. (Morton Walker wrote an editorial to commemorate my 80th birthday on page 107.)

302.Hoffer A. Alzheimer’s – An Anecdote (letter) Townsend Letter for Doctors and Patients, No.179, 107-109, 1998

303.Hoffer A. Orthomolecular Treatment for Schizophrenia. Natural Med J, 2, 12-13, 1999

304.Orthomolecular Medicine, An interview with Abram Hoffer, Latitudes 3:6-10,1998

305.Hoffer A. Aging Without Senility . Reprint from Smart Nutrients Alive, No. 204, 16-17, 1999

306.Hoffer A. Vitamin B-3 and Schizophrenia. Discovery, Recovery, Controversy. Quarry Press, Kingston, ON, 1999.

307.Hoffer A. Letter in Nutrition and Healing Newsletter, by Jonathan V Wright, March 2000, page 8. On Multiple sclerosis, niacin and histamine

308.Hoffer A. How OrthoMolecular Medicine Can Help. Finding Care for Depression, December 2000

309.Hoffer A. Vitamin B-3 and Schizophrenia. Townsend Letter for Doctors and Patients; 4/1/2001

310.Hoffer A. Vitamin B-3 Does Not Cure Tranquilizer Psychoses. Townsend Letter for Doctors and Patients, April 2001

311.Hoffer A. Selenium and AIDS – Book Corners. Townsend Letter for Doctors and Patients, November 2001

312.Hoffer A. Editorial: “Toxic” Vitamins. Journal of Orthomolecular Medicine, Vol. 18, Third and Fourth Quarters, 2003 from their Special Issue on The Safety and Efficacy of Vitamins.

313.Hoffer A. Comments on Comments on “Mega-Dose Vitamins and Minerals in the Treatment of Nonmetastatic Breast… Integr Cancer Ther .2003; 2: 155-157.

314.Hoffer A. Schizophrenia and cancer: the adrenochrome balanced morphism, Medical Hypotheses, Volume 62, Issue 3, March 2004, Pages 415-419

315.Hoffer A. Lies, damn lies and statistics: the statistics game. Townsend Letter for Doctors and Patients, October 2004

316.Hoffer A, Foster, HD: Schizophrenia and cancer: the adrenochrome balanced morphism, Med Hypotheses. 2004;62(3):415-9

317.Hoffer A, Foster, HD: The two faces of L-DOPA. Benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson’s disease, multiple sclerosis and amyotrophic lateral sclerosis. Med Hypotheses. 2004;62(2):177-81

318.Hoffer A. Niacin, Coronary disease and Longevity